Posttranscriptional	O
regulation	O
of	O
macrophage	O
tissue	B-protein
factor	I-protein
expression	O
by	O
antioxidants	O
.	O

Tissue	B-protein
factor	I-protein
(	O
TF	B-protein
)	O
expression	O
by	O
cells	O
of	O
monocyte/macrophage	B-cell_type
lineage	I-cell_type
represents	O
an	O
important	O
mechanism	O
underlying	O
the	O
initiation	O
of	O
fibrin	B-protein
deposition	O
at	O
sites	O
of	O
extravascular	O
inflammation	O
.	O

Recent	O
evidence	O
suggests	O
a	O
role	O
for	O
oxidant	O
stress	O
in	O
the	O
signalling	O
pathway	O
of	O
various	O
cell	O
types	O
by	O
virtue	O
of	O
its	O
ability	O
to	O
induce	O
DNA	O
binding	O
of	O
various	O
transcription	B-protein
factors	I-protein
,	O
including	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
and	O
AP-1	B-protein
.	O

The	O
effect	O
of	O
antioxidant	O
treatment	O
on	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-induced	O
TF	B-protein
expression	O
was	O
examined	O
in	O
murine	B-cell_type
peritoneal	I-cell_type
macrophages	I-cell_type
and	O
human	B-cell_type
monocytes	I-cell_type
.	O

Both	O
pyrrolidine	O
dithiocarbamate	O
,	O
an	O
oxidant	O
scavenger	O
,	O
and	O
N-acetyl-cysteine	O
,	O
a	O
precursor	O
of	O
the	O
endogenous	O
antioxidant	O
glutathione	O
,	O
inhibited	O
stimulation	O
of	O
macrophage	O
procoagulant	O
activity	O
by	O
LPS	O
.	O

Northern	O
blot	O
analysis	O
showed	O
that	O
neither	O
of	O
these	O
agents	O
reduced	O
LPS-stimulated	O
TF	B-protein
mRNA	O
accumulation	O
,	O
thereby	O
suggesting	O
a	O
posttranscriptional	O
mechanism	O
for	O
the	O
effect	O
.	O

Immunofluorescence	O
studies	O
of	O
human	B-cell_type
monocytes	I-cell_type
using	O
polyclonal	O
anti-TF	B-protein
antibody	I-protein
showed	O
that	O
N-acetyl-cysteine	O
treatment	O
prevented	O
the	O
characteristic	O
plasmalemmal	O
localization	O
of	O
TF	B-protein
antigen	I-protein
that	O
occurs	O
in	O
response	O
to	O
LPS	O
.	O

Western	O
blot	O
analysis	O
showed	O
that	O
N-acetyl-cysteine	O
reduced	O
the	O
accumulation	O
of	O
the	O
47-kD	B-protein
mature	I-protein
glycoprotein	I-protein
in	O
LPS-treated	B-cell_line
cells	I-cell_line
,	O
a	O
finding	O
consistent	O
with	O
the	O
results	O
of	O
the	O
immunofluorescence	O
studies	O
.	O

Furthermore	O
,	O
these	O
conditions	O
did	O
not	O
result	O
in	O
an	O
accumulation	O
of	O
the	O
less	O
mature	O
forms	O
of	O
TF	B-protein
.	O

When	O
considered	O
together	O
,	O
these	O
data	O
suggest	O
that	O
antioxidants	O
exert	O
their	O
effects	O
by	O
impairing	O
translation	O
and/or	O
by	O
causing	O
degradation	O
of	O
newly	O
translated	B-protein
protein	I-protein
.	O

The	O
effect	O
of	O
antioxidants	O
on	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
appeared	O
to	O
be	O
species	O
specific	O
,	O
with	O
no	O
effect	O
on	O
LPS-induced	O
tumor	O
necrosis	O
factor	O
in	O
murine	O
cells	O
,	O
but	O
with	O
inhibition	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

The	O
posttranscriptional	O
effect	O
of	O
antioxidants	O
on	O
TF	B-protein
expression	O
data	O
suggests	O
a	O
novel	O
mechanism	O
whereby	O
these	O
agents	O
might	O
modulate	O
monocyte	B-cell_type
/macrophage	B-cell_type
activation	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Posttranscriptional	NULL
Regulation	NULL
of	NULL
Macrophage	NULL
Tissue	NULL
Factor	NULL
Expression	NULL
by	NULL
Antioxidants	NULL
By	NULL
G.F.	NULL
Brisseau	NULL
,	NULL
A.P.B	NULL
.	NULL

Dackiw	NULL
,	NULL
P.Y.C	NULL
.	NULL

Cheung	NULL
,	NULL
N.	NULL
Christie	NULL
,	NULL
and	NULL
O.D	NULL
.	NULL

Rotstein	NULL
Tissue	NULL
factor	NULL
(	NULL
TF	NULL
)	NULL
expression	NULL
by	NULL
cells	NULL
of	NULL
monocyte/macrophage	NULL
lineage	NULL
represents	NULL
an	NULL
important	NULL
mechanism	NULL
underlying	NULL
the	NULL
initiation	NULL
of	NULL
fibrin	NULL
deposition	NULL
at	NULL
sites	NULL
of	NULL
extravascular	NULL
inflammation	NULL
.	NULL

Recent	NULL
evidence	NULL
suggests	NULL
a	NULL
role	NULL
for	NULL
oxidant	NULL
stress	NULL
in	NULL
the	NULL
signalling	NULL
pathway	NULL
of	NULL
various	NULL
cell	NULL
types	NULL
by	NULL
virtue	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
DNA	NULL
binding	NULL
of	NULL
various	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
antioxidant	NULL
treatment	NULL
on	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-in-duced	NULL
TF	NULL
expression	NULL
was	NULL
examined	NULL
in	NULL
murine	NULL
peritoneal	NULL
macrophages	NULL
and	NULL
human	NULL
monocytes	NULL
.	NULL

Both	NULL
pyrrolidine	NULL
di-thiocarbamate	NULL
,	NULL
an	NULL
oxidant	NULL
scavenger	NULL
,	NULL
and	NULL
N-acetyl-cysteine	NULL
,	NULL
a	NULL
precursor	NULL
of	NULL
the	NULL
endogenous	NULL
antioxidant	NULL
glutathione	NULL
,	NULL
inhibited	NULL
stimulation	NULL
of	NULL
macrophage	NULL
procoagulant	NULL
activity	NULL
by	NULL
LPS	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
neither	NULL
of	NULL
these	NULL
agents	NULL
reduced	NULL
LPS-stimulated	NULL
TF	NULL
mRNA	NULL
accumulation	NULL
,	NULL
thereby	NULL
suggesting	NULL
a	NULL
posttranscriptional	NULL
mechanism	NULL
for	NULL
the	NULL
effect	NULL
.	NULL

Immunofluorescence	NULL
studies	NULL
of	NULL
human	NULL
monocytes	NULL
using	NULL
polyclonal	NULL
anti-TF	NULL
antibody	NULL
showed	NULL
that	NULL
N-acetyl-cys-	NULL
EACTIVE	NULL
OXYGEN	NULL
species	NULL
(	NULL
ROS	NULL
)	NULL
have	NULL
traditionally	NULL
been	NULL
considered	NULL
to	NULL
be	NULL
toxic	NULL
molecules	NULL
effecting	NULL
tissue	NULL
injury	NULL
in	NULL
their	NULL
local	NULL
environment	NULL
.	NULL
'	NULL

Their	NULL
central	NULL
role	NULL
in	NULL
the	NULL
pathophysiology	NULL
of	NULL
several	NULL
disease	NULL
processes	NULL
has	NULL
been	NULL
well	NULL
demonstrated	NULL
.	NULL

These	NULL
processes	NULL
include	NULL
ischemia/reperfusion	NULL
syndromes	NULL
,	NULL
organ	NULL
dysfunction	NULL
associated	NULL
with	NULL
systemic	NULL
inflammatory	NULL
states	NULL
,	NULL
tissue	NULL
injury	NULL
initiated	NULL
by	NULL
exogenous	NULL
chem-icals	NULL
,	NULL
and	NULL
even	NULL
the	NULL
aging	NULL
process	NULL
.	NULL
``	NULL

''	NULL
The	NULL
common	NULL
mechanism	NULL
underlying	NULL
these	NULL
effects	NULL
is	NULL
the	NULL
destruction	NULL
of	NULL
membranes	NULL
,	NULL
proteins	NULL
,	NULL
and	NULL
nucleic	NULL
acids	NULL
by	NULL
toxic	NULL
oxygen	NULL
metabolites	NULL
generated	NULL
by	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
or	NULL
signals	NULL
.	NULL

However	NULL
,	NULL
several	NULL
lines	NULL
of	NULL
evidence	NULL
suggest	NULL
that	NULL
ROS	NULL
may	NULL
contribute	NULL
to	NULL
cell	NULL
activation	NULL
.	NULL

First	NULL
,	NULL
ROS	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
mitogenic	NULL
and	NULL
act	NULL
as	NULL
tumor	NULL
promoters	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
Secondly	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
oxidants	NULL
such	NULL
as	NULL
hydrogen	NULL
peroxide	NULL
(	NULL
H	NULL
;	NULL
,0	NULL
;	NULL
)	NULL
and	NULL
xanthine/xanthine	NULL
oxidase	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
of	NULL
the	NULL
early	NULL
response	NULL
genes	NULL
,	NULL
including	NULL
c-fos	NULL
,	NULL
c-myc	NULL
,	NULL
c-jun	NULL
,	NULL
egr-1	NULL
,	NULL
and	NULL
JE	NULL
.	NULL
``	NULL

Thirdly	NULL
,	NULL
stimuli	NULL
known	NULL
to	NULL
induce	NULL
oxidant	NULL
stress	NULL
such	NULL
as	NULL
UV	NULL
irradiation	NULL
are	NULL
also	NULL
able	NULL
to	NULL
induce	NULL
early	NULL
gene	NULL
expression	NULL
.	NULL

Finally	NULL
,	NULL
ROS	NULL
initiate	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
by	NULL
various	NULL
transcription	NULL
factors	NULL
.	NULL

Devary	NULL
et	NULL
al°	NULL
showed	NULL
that	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
UV	NULL
irradiation	NULL
initiated	NULL
AP-1	NULL
binding	NULL
in	NULL
HeLa	NULL
cells	NULL
,	NULL
whereas	NULL
others	NULL
'	NULL
``	NULL
have	NULL
shown	NULL
that	NULL
H	NULL
,	NULL
O	NULL
,	NULL
was	NULL
able	NULL
to	NULL
induce	NULL
the	NULL
translocation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
nuclear	NULL
factor	NULL
KB	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
from	NULL
the	NULL
cytoplasm	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
cause	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
HIV-1	NULL
LTR	NULL
)	NULL
,	NULL
a	NULL
gene	NULL
dependent	NULL
on	NULL
intact	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
.	NULL

The	NULL
effect	NULL
was	NULL
blocked	NULL
by	NULL
various	NULL
thiol	NULL
compounds	NULL
as	NULL
well	NULL
as	NULL
by	NULL
other	NULL
antioxidants	NULL
such	NULL
as	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
these	NULL
antioxidants	NULL
also	NULL
blocked	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
induced	NULL
by	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
lectins	NULL
,	NULL
and	NULL
the	NULL
cytokines	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
.	NULL
'	NULL

''	NULL
When	NULL
considered	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
oxidants	NULL
may	NULL
play	NULL
a	NULL
central	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
various	NULL
genes	NULL
,	NULL
particularly	NULL
those	NULL
endowed	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
and/or	NULL
AP-1	NULL
binding	NULL
sites	NULL
in	NULL
their	NULL
promoter/enhancer	NULL
regions	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
85	NULL
,	NULL
No	NULL
4	NULL
(	NULL
February	NULL
15	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
1025-1035	NULL
teine	NULL
treatment	NULL
prevented	NULL
the	NULL
characteristic	NULL
plasmalemmal	NULL
localization	NULL
of	NULL
TF	NULL
antigen	NULL
that	NULL
occurs	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
N-acetyl-cysteine	NULL
reduced	NULL
the	NULL
accumulation	NULL
of	NULL
the	NULL
47-kD	NULL
mature	NULL
glycoprotein	NULL
in	NULL
LPS-treated	NULL
cells	NULL
,	NULL
a	NULL
finding	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
immunofluorescence	NULL
studies	NULL
.	NULL

Furthermore	NULL
,	NULL
these	NULL
conditions	NULL
did	NULL
not	NULL
result	NULL
in	NULL
an	NULL
accumulation	NULL
of	NULL
the	NULL
less	NULL
mature	NULL
forms	NULL
of	NULL
TF	NULL
.	NULL

When	NULL
considered	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
antioxidants	NULL
exert	NULL
their	NULL
effects	NULL
by	NULL
impairing	NULL
translation	NULL
and/or	NULL
by	NULL
causing	NULL
degradation	NULL
of	NULL
newly	NULL
translated	NULL
protein	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
antioxidants	NULL
on	NULL
tumor	NULL
necrosis	NULL
factor	NULL
appeared	NULL
to	NULL
be	NULL
species	NULL
specific	NULL
,	NULL
with	NULL
no	NULL
effect	NULL
on	NULL
LPS-induced	NULL
tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
murine	NULL
cells	NULL
,	NULL
but	NULL
with	NULL
inhibition	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

The	NULL
posttranscriptional	NULL
effect	NULL
of	NULL
antioxidants	NULL
on	NULL
TF	NULL
expression	NULL
data	NULL
suggests	NULL
a	NULL
novel	NULL
mechanism	NULL
whereby	NULL
these	NULL
agents	NULL
might	NULL
modulate	NULL
monocyte/macrophage	NULL
activation	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

Local	NULL
fibrin	NULL
deposition	NULL
mediated	NULL
via	NULL
the	NULL
expression	NULL
of	NULL
cell-associated	NULL
procoagulants	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
patho-genesis	NULL
of	NULL
several	NULL
disease	NULL
processes	NULL
,	NULL
including	NULL
viral	NULL
hepati-tis	NULL
,	NULL
>	NULL
``	NULL
lupus	NULL
glomerulonephritis	NULL
,	NULL
'*	NULL
``	NULL
``	NULL
acute	NULL
lung	NULL
injury	NULL
,	NULL
``	NULL
``	NULL
and	NULL
bacterial	NULL
abscesses	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Although	NULL
cellular	NULL
procoagulants	NULL
represent	NULL
a	NULL
heterogeneous	NULL
group	NULL
of	NULL
molecules	NULL
,	NULL
tissue	NULL
factor	NULL
(	NULL
TF	NULL
)	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
predominant	NULL
procoagulant	NULL
molecule	NULL
synthesized	NULL
in	NULL
response	NULL
to	NULL
most	NULL
proinflammatory	NULL
stimuli	NULL
.	NULL

This	NULL
47-kD	NULL
surface-expressed	NULL
glycoprotein	NULL
initiates	NULL
the	NULL
extrinsic	NULL
pathway	NULL
of	NULL
the	NULL
coagulation	NULL
cascade	NULL
by	NULL
binding	NULL
factor	NULL
VII	NULL
and	NULL
augmenting	NULL
its	NULL
conversion	NULL
to	NULL
factor	NULL
Va.	NULL
``	NULL
The	NULL
resulting	NULL
factor	NULL
VII/VIIa	NULL
complex	NULL
activates	NULL
both	NULL
factor	NULL
X	NULL
and	NULL
factor	NULL
IX	NULL
,	NULL
leading	NULL
to	NULL
ultimate	NULL
clot	NULL
formation	NULL
.	NULL

The	NULL
complete	NULL
sequences	NULL
for	NULL
both	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
TF	NULL
genes	NULL
have	NULL
been	NULL
re-ported	NULL
``	NULL
and	NULL
both	NULL
have	NULL
a	NULL
56-bp	NULL
LPS	NULL
response	NULL
element	NULL
within	NULL
their	NULL
promoters	NULL
.	NULL

This	NULL
region	NULL
is	NULL
characterized	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
AP-1	NULL
and	NULL
one	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

Binding	NULL
to	NULL
both	NULL
the	NULL
distal	NULL
AP-1	NULL
and	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
is	NULL
required	NULL
for	NULL
optimal	NULL
transcription	NULL
of	NULL
the	NULL
TF	NULL
gene	NULL
.	NULL
``	NULL

Based	NULL
on	NULL
the	NULL
demonstrated	NULL
ability	NULL
of	NULL
oxidants	NULL
to	NULL
induce	NULL
binding	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
to	NULL
their	NULL
respective	NULL
DNA	NULL
binding	NULL
sites	NULL
and	NULL
initiate	NULL
gene	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Surgery	NULL
,	NULL
University	NULL
of	NULL
Toronto	NULL
,	NULL
and	NULL
the	NULL
Toronto	NULL
Hospital	NULL
Research	NULL
Institute	NULL
Toronto	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
.	NULL

Submitted	NULL
March	NULL
14	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
October	NULL
19	NULL
,	NULL
1994	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
.	NULL

G.F.B	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
an	NULL
MRC-Industry	NULL
Fellowship	NULL
and	NULL
Merck	NULL
Sharp	NULL
and	NULL
Dohme-American	NULL
College	NULL
of	NULL
Surgeons	NULL
Scholarship	NULL
.	NULL

A.P.B.D	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
the	NULL
Miles	NULL
Fellowship	NULL
from	NULL
the	NULL
Canadian	NULL
Infectious	NULL
Disease	NULL
Society	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
O.D	NULL
.	NULL

Rotstein	NULL
,	NULL
MD	NULL
,	NULL
Toronto	NULL
Hospital	NULL
,	NULL
200	NULL
Elizabeth	NULL
St	NULL
,	NULL
Eaton	NULL
North	NULL
#	NULL
9-236	NULL
,	NULL
Toronto	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
MSG	NULL
2C4	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
'	NULL
``	NULL
'advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/95/8504-0019	NULL
$	NULL
3.00/0	NULL
1025	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1026	NULL
200000	NULL
180000	NULL
160000	NULL
140000	NULL
120000	NULL
100000	NULL
80000	NULL
60000	NULL
40000	NULL
20000	NULL
.	NULL

LPS+NAC	NULL
o	NULL
LPS+PDTC	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
150	NULL
180210	NULL
240	NULL
LPS	NULL
Chemiluminescence	NULL
(	NULL
ecpm	NULL
)	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
transcription	NULL
,	NULL
we	NULL
performed	NULL
experiments	NULL
to	NULL
examine	NULL
the	NULL
effect	NULL
of	NULL
antioxidants	NULL
on	NULL
TF	NULL
functional	NULL
activity	NULL
and	NULL
gene	NULL
expression	NULL
in	NULL
stimulated	NULL
murine	NULL
macrophages	NULL
and	NULL
human	NULL
monocytes	NULL
.	NULL

These	NULL
studies	NULL
showed	NULL
that	NULL
both	NULL
N-acetyl-cysteine	NULL
(	NULL
NAC	NULL
)	NULL
and	NULL
pyrrolidine	NULL
dithiocarbamate	NULL
(	NULL
PDTC	NULL
)	NULL
inhibited	NULL
the	NULL
increase	NULL
in	NULL
macrophage/monocyte	NULL
TF	NULL
activity	NULL
induced	NULL
by	NULL
LPS	NULL
.	NULL

However	NULL
,	NULL
this	NULL
effect	NULL
was	NULL
not	NULL
mediated	NULL
by	NULL
a	NULL
reduction	NULL
in	NULL
TF	NULL
gene	NULL
expression	NULL
but	NULL
rather	NULL
by	NULL
an	NULL
alteration	NULL
in	NULL
the	NULL
posttranscriptional	NULL
modification	NULL
of	NULL
the	NULL
protein	NULL
that	NULL
prevented	NULL
its	NULL
functional	NULL
expression	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Animals	NULL
.	NULL

Six-	NULL
to	NULL
eight-week-old	NULL
female	NULL
Swiss	NULL
Webster	NULL
mice	NULL
were	NULL
obtained	NULL
from	NULL
Taconic	NULL
Farms	NULL
.	NULL

After	NULL
delivery	NULL
to	NULL
our	NULL
animal	NULL
facility	NULL
,	NULL
animals	NULL
were	NULL
allowed	NULL
to	NULL
acclimatize	NULL
for	NULL
2	NULL
to	NULL
4	NULL
days	NULL
before	NULL
use	NULL
in	NULL
these	NULL
studies	NULL
.	NULL

Animals	NULL
were	NULL
then	NULL
maintained	NULL
in	NULL
colonies	NULL
of	NULL
no	NULL
more	NULL
than	NULL
five	NULL
animals	NULL
per	NULL
cage	NULL
and	NULL
were	NULL
fed	NULL
standard	NULL
mouse	NULL
chow	NULL
and	NULL
water	NULL
ad	NULL
libitum	NULL
.	NULL

Materials	NULL
.	NULL

Hanks	NULL
'	NULL
Balanced	NULL
Salt	NULL
Solution	NULL
(	NULL
HBSS	NULL
;	NULL
Ca®*	NULL
and	NULL
Mg**	NULL
free	NULL
)	NULL
and	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
FBS	NULL
)	NULL
were	NULL
from	NULL
GIBCO	NULL
(	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Escherichia	NULL
coli	NULL
LPS	NULL
,	NULL
zymosan-derived	NULL
from	NULL
Saccharo-myces	NULL
cerevisiae	NULL
,	NULL
molecular	NULL
mass	NULL
standards	NULL
,	NULL
Coomassie	NULL
blue	NULL
,	NULL
Noni-det	NULL
P-40	NULL
,	NULL
HEPES	NULL
,	NULL
rabbit	NULL
brain	NULL
thromboplastin	NULL
,	NULL
PDTC	NULL
,	NULL
pyrrolidine	NULL
,	NULL
pyroglutamic	NULL
acid	NULL
,	NULL
NAC	NULL
,	NULL
glutamine	NULL
,	NULL
and	NULL
RPMI	NULL
1640	NULL
medium	NULL
were	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Immobilon	NULL
was	NULL
from	NULL
Millipore	NULL
(	NULL
Bed-ford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Heparin	NULL
sodium	NULL
(	NULL
1,000	NULL
USP	NULL
U/mL	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Organon	NULL
Teknika	NULL
(	NULL
Toronto	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

The	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
directed	NULL
against	NULL
human	NULL
TF	NULL
was	NULL
obtained	NULL
from	NULL
Dr	NULL
Ronald	NULL
Bach	NULL
(	NULL
Uni-versity	NULL
of	NULL
Minnesota	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL
``	NULL

The	NULL
monoclonal	NULL
hamster	NULL
antimurine	NULL
TNF	NULL
antibody	NULL
was	NULL
from	NULL
Genzyme	NULL
Corp	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
the	NULL
polyclonal	NULL
rabbit	NULL
antimurine	NULL
TNF	NULL
antibody	NULL
was	NULL
from	NULL
Endogen	NULL
Inc	NULL
(	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
goat	NULL
antirabbit	NULL
IgG	NULL
conjugated	NULL
with	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
goat	NULL
antirabbit	NULL
IgG	NULL
conjugated	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
were	NULL
from	NULL
Jackson	NULL
Immunoresearch	NULL
Labora-tories	NULL
,	NULL
Inc	NULL
(	NULL
Philadelphia	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Powdered	NULL
Brewer	NULL
's	NULL
thioglycolate	NULL
was	NULL
obtained	NULL
from	NULL
Difco	NULL
(	NULL
Detroit	NULL
,	NULL
MI	NULL
)	NULL
.	NULL

Solutions	NULL
.	NULL

-	NULL
Supplemented	NULL
RPMI	NULL
contained	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FBS	NULL
,	NULL
L-glutamine	NULL
(	NULL
2	NULL
mmoVL	NULL
)	NULL
,	NULL
and	NULL
25	NULL
mmoVL	NULL
HEPES	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

Zymosan	NULL
and	NULL
LPS	NULL
were	NULL
suspended	NULL
in	NULL
sterile	NULL
water	NULL
.	NULL

Cell	NULL
preparation	NULL
.	NULL

Murine	NULL
peritoneal	NULL
macrophages	NULL
were	NULL
harvested	NULL
by	NULL
peritoneal	NULL
lavage	NULL
,	NULL
using	NULL
10	NULL
mL	NULL
of	NULL
sterile	NULL
HBSS	NULL
,	NULL
4	NULL
days	NULL
after	NULL
the	NULL
intraperitoneal	NULL
injection	NULL
of	NULL
2	NULL
mL	NULL
of	NULL
thioglycolate	NULL
medium	NULL
.	NULL

Lavage	NULL
fluids	NULL
were	NULL
pooled	NULL
and	NULL
centrifuged	NULL
at	NULL
200g	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
cell-containing	NULL
pellet	NULL
was	NULL
then	NULL
washed	NULL
in	NULL
sterile	NULL
HBSS	NULL
and	NULL
Control	NULL
LPS+PDTC	NULL
0.16	NULL
+£0.05	NULL
LPS+NAC	NULL
0.3010.11	NULL
BRISSEAU	NULL
ET	NULL
AL	NULL
Area	NULL
Under	NULL
Curve	NULL
1.65	NULL
£0.31	NULL
3.08	NULL
£0.42	NULL
Fig	NULL
1	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
antioxidants	NULL
on	NULL
LPS-induced	NULL
luminol-dependent	NULL
chemiluminescence	NULL
.	NULL

Murine	NULL
macrophages	NULL
(	NULL
10°/mL	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
either	NULL
PDTC	NULL
{	NULL
1	NULL
mmol/L	NULL
)	NULL
or	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
)	NULL
for	NULL
45	NULL
minutes	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
.	NULL

Changes	NULL
in	NULL
chemiluminescence	NULL
were	NULL
recorded	NULL
over	NULL
a	NULL
4-hour	NULL
period	NULL
in	NULL
an	NULL
automated	NULL
luminometer	NULL
.	NULL

A	NULL
representative	NULL
trace	NULL
is	NULL
shown	NULL
.	NULL

Relative	NULL
total	NULL
oxidant	NULL
production	NULL
obtained	NULL
by	NULL
integration	NULL
of	NULL
the	NULL
area	NULL
under	NULL
the	NULL
curve	NULL
is	NULL
shown	NULL
at	NULL
the	NULL
right	NULL
{	NULL
mean	NULL
+	NULL
SEM	NULL
,	NULL
n	NULL
=	NULL
3	NULL
)	NULL
.	NULL

centrifuged	NULL
again	NULL
at	NULL
200g	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
discarded	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
5	NULL
mL	NULL
of	NULL
sterile	NULL
water	NULL
for	NULL
15	NULL
seconds	NULL
to	NULL
lyse	NULL
any	NULL
red	NULL
blood	NULL
cells	NULL
and	NULL
then	NULL
diluted	NULL
to	NULL
45	NULL
mL	NULL
with	NULL
sterile	NULL
HBSS	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
sedimented	NULL
again	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
and	NULL
then	NULL
counted	NULL
using	NULL
a	NULL
hemocy-tometer	NULL
.	NULL

The	NULL
cell	NULL
population	NULL
was	NULL
then	NULL
diluted	NULL
to	NULL
1	NULL
to	NULL
2	NULL
X	NULL
10°	NULL
cells/	NULL
mL	NULL
in	NULL
supplemented	NULL
RPMI	NULL
and	NULL
aliquoted	NULL
into	NULL
polypropylene	NULL
tissue	NULL
culture	NULL
tubes	NULL
.	NULL

This	NULL
technique	NULL
generated	NULL
a	NULL
cell	NULL
suspension	NULL
with	NULL
a	NULL
viability	NULL
in	NULL
excess	NULL
of	NULL
95	NULL
%	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
,	NULL
and	NULL
a	NULL
cell	NULL
population	NULL
of	NULL
80	NULL
%	NULL
to	NULL
90	NULL
%	NULL
macrophages	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
nonspecific	NULL
esterase	NULL
staining	NULL
,	NULL
Wright	NULL
's	NULL
staining	NULL
,	NULL
and	NULL
transmission	NULL
electron	NULL
microscopy	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
(	NULL
PBM	NULL
)	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
normal	NULL
healthy	NULL
donors	NULL
by	NULL
drawing	NULL
20	NULL
mL	NULL
of	NULL
blood	NULL
into	NULL
tubes	NULL
containing	NULL
heparin	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
layered	NULL
onto	NULL
Ficoll-Hypaque	NULL
and	NULL
centrifuged	NULL
at	NULL
400g	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

The	NULL
layer	NULL
containing	NULL
PBM	NULL
cells	NULL
was	NULL
then	NULL
aspirated	NULL
,	NULL
washed	NULL
twice	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
supplemented	NULL
RPML	NULL
.	NULL

This	NULL
cell	NULL
population	NULL
contained	NULL
25	NULL
%	NULL
to	NULL
35	NULL
%	NULL
monocytes	NULL
as	NULL
assessed	NULL
by	NULL
Wright	NULL
's	NULL
stain	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
for	NULL
0.5	NULL
to	NULL
6	NULL
hours	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
with	NULL
either	NULL
LPS	NULL
or	NULL
zymosan	NULL
.	NULL

The	NULL
antioxidant	NULL
to	NULL
be	NULL
tested	NULL
was	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
and	NULL
was	NULL
present	NULL
throughout	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
except	NULL
in	NULL
the	NULL
delayed	NULL
addition	NULL
experiments	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
cells	NULL
were	NULL
sedimented	NULL
by	NULL
centrifugation	NULL
at	NULL
200g	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

Supernatants	NULL
were	NULL
aspirated	NULL
and	NULL
frozen	NULL
at	NULL
-70°C	NULL
for	NULL
later	NULL
measurement	NULL
of	NULL
TNF	NULL
.	NULL

Cell	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
RPMI	NULL
1640	NULL
and	NULL
frozen	NULL
at	NULL
~70°C	NULL
for	NULL
measurement	NULL
of	NULL
procoagulant	NULL
activity	NULL
(	NULL
PCA	NULL
)	NULL
.	NULL

For	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
rapidly	NULL
sedimented	NULL
and	NULL
pellets	NULL
were	NULL
immediately	NULL
solubilized	NULL
in	NULL
boiling	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
.	NULL

Measurement	NULL
of	NULL
macrophage	NULL
PCA	NULL
.	NULL

-	NULL
PCA	NULL
in	NULL
freeze-thawed	NULL
macrophages	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
their	NULL
capacity	NULL
to	NULL
shorten	NULL
the	NULL
spontaneous	NULL
clotting	NULL
time	NULL
of	NULL
normal	NULL
citrated	NULL
human	NULL
plasma	NULL
in	NULL
a	NULL
one-stage	NULL
clotting	NULL
assay	NULL
.	NULL
``	NULL

An	NULL
80	NULL
LL	NULL
sample	NULL
of	NULL
macrophage	NULL
cell	NULL
lysates	NULL
obtained	NULL
by	NULL
freeze-thawing	NULL
was	NULL
added	NULL
to	NULL
80	NULL
gL	NULL
of	NULL
citrated	NULL
normal	NULL
human	NULL
platelet-poor	NULL
plasma	NULL
,	NULL
and	NULL
then	NULL
80	NULL
LL	NULL
of	NULL
25	NULL
mmol/L	NULL
CaCl	NULL
;	NULL
was	NULL
added	NULL
to	NULL
initiate	NULL
the	NULL
reaction	NULL
.	NULL

The	NULL
time	NULL
taken	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
fibrin	NULL
gel	NULL
at	NULL
37°C	NULL
with	NULL
gentle	NULL
agitation	NULL
was	NULL
recorded	NULL
.	NULL

Previous	NULL
studies	NULL
by	NULL
Lando	NULL
and	NULL
Edgington	NULL
``	NULL
``	NULL
indicated	NULL
that	NULL
LPS-induced	NULL
murine	NULL
macrophage	NULL
PCA	NULL
is	NULL
only	NULL
slightly	NULL
less	NULL
effective	NULL
at	NULL
shortening	NULL
the	NULL
clotting	NULL
time	NULL
of	NULL
human	NULL
plasma	NULL
than	NULL
at	NULL
shortening	NULL
the	NULL
clotting	NULL
time	NULL
of	NULL
mouse	NULL
plasma	NULL
.	NULL

Clotting	NULL
times	NULL
were	NULL
converted	NULL
to	NULL
milliunits	NULL
of	NULL
PCA	NULL
by	NULL
comparison	NULL
with	NULL
clotting	NULL
times	NULL
of	NULL
a	NULL
rabbit	NULL
brain	NULL
thromboplastin	NULL
standard	NULL
in	NULL
which	NULL
36	NULL
mg	NULL
(	NULL
dry	NULL
weight	NULL
)	NULL
per	NULL
milliliter	NULL
was	NULL
assigned	NULL
a	NULL
value	NULL
of	NULL
100,000	NULL
mU	NULL
of	NULL
PCA	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
PCA	NULL
from	NULL
a	NULL
baseline	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ANTIOXIDANTS	NULL
AND	NULL
MACROPHAGE	NULL
TISSUE	NULL
FACTOR	NULL
of	NULL
150	NULL
mU/L	NULL
x	NULL
10°	NULL
macrophages	NULL
to	NULL
1,500	NULL
mU/10°	NULL
macrophages	NULL
in	NULL
cells	NULL
stimulated	NULL
by	NULL
LPS	NULL
alone	NULL
represented	NULL
a	NULL
shortening	NULL
of	NULL
the	NULL
clotting	NULL
time	NULL
from	NULL
85	NULL
to	NULL
57	NULL
seconds	NULL
.	NULL

The	NULL
assay	NULL
was	NULL
used	NULL
over	NULL
the	NULL
range	NULL
of	NULL
10	NULL
to	NULL
10,000	NULL
mU	NULL
of	NULL
PCA	NULL
,	NULL
this	NULL
range	NULL
being	NULL
linear	NULL
with	NULL
normal	NULL
plasma	NULL
substrate	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
PCA	NULL
induced	NULL
with	NULL
E	NULL
A	NULL
en	NULL
ast	NULL
©	NULL
°	NULL
>	NULL
1	NULL
£	NULL
<	NULL
O	NULL
A	NULL
.	NULL

5°	NULL
;	NULL
saggg	NULL
‘	NULL
PGA	NULL
|	NULL
Pyrro	NULL
.	NULL

5	NULL
Lal	NULL
2	NULL
LPS	NULL
+PDTC	NULL
(	NULL
uM	NULL
)	NULL
B	NULL
Ld	NULL
o-	NULL
-	NULL
2000	NULL
+	NULL
n	NULL
2	NULL
.	NULL

*-	NULL
1500	NULL
+	NULL
«	NULL
~	NULL
ta	NULL
1000	NULL
+	NULL
Nut	NULL
<	NULL
G	NULL
&	NULL
-	NULL
soo	NULL
]	NULL
A	NULL
0	NULL
C	NULL
[	NULL
3	NULL
8	NULL
8	NULL
1000	NULL
PCA	NULL
(	NULL
mU/10°	NULL
MS	NULL
)	NULL
$	NULL
$	NULL
Medium	NULL
LPS	NULL
0	NULL
1	NULL
Delay	NULL
of	NULL
addition	NULL
(	NULL
hr	NULL
)	NULL
2	NULL
3	NULL
1027	NULL
coli	NULL
LPS	NULL
has	NULL
TF-like	NULL
activities	NULL
,	NULL
making	NULL
comparison	NULL
with	NULL
a	NULL
thromboplastin	NULL
standard	NULL
valid	NULL
.	NULL
``	NULL

TF	NULL
detection	NULL
by	NULL
immunofluorescence	NULL
.	NULL

-	NULL
PBM	NULL
cells	NULL
were	NULL
incubated	NULL
on	NULL
poly-L-lysine-coated	NULL
glass	NULL
coverslips	NULL
for	NULL
20	NULL
minutes	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
and	NULL
nonadherent	NULL
cells	NULL
were	NULL
washed	NULL
off	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
then	NULL
fixed	NULL
and	NULL
permeabilized	NULL
in	NULL
cold	NULL
acetone	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
polyclonal	NULL
antihuman	NULL
TF	NULL
antibody	NULL
in	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
stained	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-labeled	NULL
secondary	NULL
antibody	NULL
for	NULL
a	NULL
further	NULL
30	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
viewed	NULL
with	NULL
a	NULL
Nikon	NULL
Diphot-TMD	NULL
epifluorescence	NULL
microscope	NULL
(	NULL
Nikon	NULL
Canada	NULL
,	NULL
Inc	NULL
,	NULL
Toronto	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

TF	NULL
detection	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

TF	NULL
expression	NULL
in	NULL
human	NULL
PBM	NULL
was	NULL
determined	NULL
by	NULL
immunoblotting	NULL
with	NULL
polyclonal	NULL
antihuman	NULL
TF	NULL
antibodies	NULL
.	NULL
``	NULL

After	NULL
electrophoresis	NULL
on	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
blotted	NULL
onto	NULL
Immobilon	NULL
using	NULL
the	NULL
Bio-Rad	NULL
Mini	NULL
Trans-Blot	NULL
system	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Richmond	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
100	NULL
V.	NULL
The	NULL
blot	NULL
was	NULL
incubated	NULL
with	NULL
10	NULL
mL	NULL
of	NULL
blocking	NULL
solution	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
a	NULL
1/1,000	NULL
dilution	NULL
of	NULL
the	NULL
primary	NULL
antibody	NULL
for	NULL
2	NULL
hours	NULL
while	NULL
shaking	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
then	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
antibody	NULL
buffer	NULL
solution	NULL
and	NULL
incubated	NULL
with	NULL
a	NULL
1/5,000	NULL
dilution	NULL
of	NULL
anti-IgG	NULL
antibody	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
washed	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
quantitated	NULL
using	NULL
an	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
ECL	NULL
;	NULL
Amersham	NULL
,	NULL
Arlington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.28	NULL
Measurement	NULL
of	NULL
TNF	NULL
.	NULL

TNF	NULL
in	NULL
supernatants	NULL
was	NULL
measured	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
.	NULL

The	NULL
antibody	NULL
sandwich	NULL
was	NULL
detected	NULL
by	NULL
fluorescence	NULL
.	NULL
``	NULL

Microtiter	NULL
plates	NULL
were	NULL
coated	NULL
with	NULL
a	NULL
monoclonal	NULL
antimurine	NULL
TNF	NULL
antibody	NULL
,	NULL
incubated	NULL
with	NULL
sam-ples	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
exposed	NULL
to	NULL
the	NULL
polyclonal	NULL
rabbit	NULL
antimurine	NULL
TNF	NULL
antibody	NULL
.	NULL

The	NULL
enzyme	NULL
sandwich	NULL
was	NULL
then	NULL
incubated	NULL
with	NULL
goat	NULL
antirabbit	NULL
IgG	NULL
alkaline	NULL
phosphatase	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
substrate	NULL
solution	NULL
,	NULL
5-fluorosalicyl	NULL
phos-phate	NULL
,	NULL
and	NULL
the	NULL
developing	NULL
reagent	NULL
,	NULL
Terbium-EDTA	NULL
.	NULL

The	NULL
fluorescence	NULL
was	NULL
measured	NULL
with	NULL
a	NULL
time-resolved	NULL
fluorometer	NULL
and	NULL
the	NULL
calibration	NULL
curve	NULL
and	NULL
the	NULL
data	NULL
reduction	NULL
were	NULL
performed	NULL
by	NULL
automatic	NULL
immuno-analyzer	NULL
(	NULL
Cyber	NULL
Fluor	NULL
615	NULL
;	NULL
Scintrex	NULL
,	NULL
Concord	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

Measurement	NULL
of	NULL
ROS	NULL
.	NULL

-	NULL
ROS	NULL
were	NULL
determined	NULL
by	NULL
luminol-dependent	NULL
chemiluminescence	NULL
according	NULL
to	NULL
Allen	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
10°	NULL
macrophages	NULL
in	NULL
a	NULL
luminol-balanced	NULL
salt	NULL
solution	NULL
were	NULL
added	NULL
to	NULL
polystyrene	NULL
tubes	NULL
and	NULL
placed	NULL
in	NULL
an	NULL
automated	NULL
luminometer	NULL
(	NULL
Axis	NULL
;	NULL
ExOxEmis	NULL
,	NULL
San	NULL
Antonio	NULL
,	NULL
TX	NULL
)	NULL
at	NULL
37°C	NULL
for	NULL
45	NULL
minutes	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
treated	NULL
with	NULL
LPS	NULL
or	NULL
zymosan	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
antioxidants	NULL
,	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
(	NULL
A	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
PDTC	NULL
on	NULL
LPS-induced	NULL
PCA	NULL
.	NULL

Murine	NULL
macrophages	NULL
(	NULL
10®/mL	NULL
)	NULL
were	NULL
treated	NULL
for	NULL
4	NULL
hours	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
varying	NULL
concentrations	NULL
of	NULL
PDTC	NULL
(	NULL
0	NULL
to	NULL
5	NULL
mmol/L	NULL
)	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
pelletted	NULL
and	NULL
frozen	NULL
at	NULL
-70°C	NULL
for	NULL
later	NULL
assay	NULL
of	NULL
PCA	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

In	NULL
some	NULL
studies	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
pyroglutamic	NULL
acid	NULL
(	NULL
PGA	NULL
;	NULL
1	NULL
mmol/L	NULL
)	NULL
or	NULL
pyrrolidine	NULL
(	NULL
Pyrro	NULL
;	NULL
1	NULL
mmol/L	NULL
)	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
five	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

(	NULL
D	NULL
)	NULL
LPS	NULL
;	NULL
(	NULL
M	NULL
)	NULL
medium	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Time	NULL
course	NULL
of	NULL
PCA	NULL
induction	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PDTC	NULL
.	NULL

Murine	NULL
macrophages	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
)	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
.	NULL

At	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
hours	NULL
,	NULL
cells	NULL
were	NULL
pelletted	NULL
and	NULL
frozen	NULL
for	NULL
later	NULL
PCA	NULL
assay	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

*P	NULL
<	NULL
.05	NULL
versus	NULL
all	NULL
other	NULL
groups	NULL
at	NULL
same	NULL
time	NULL
point	NULL
.	NULL

(	NULL
0	NULL
)	NULL
Medium	NULL
;	NULL
(	NULL
@	NULL
)	NULL
LPS	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
;	NULL
(	NULL
C	NULL
)	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
)	NULL
;	NULL
(	NULL
M	NULL
)	NULL
LPS	NULL
+	NULL
PDTC	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Effect	NULL
of	NULL
delayed	NULL
addition	NULL
of	NULL
PDTC	NULL
on	NULL
LPS-induced	NULL
PCA	NULL
.	NULL

Murine	NULL
macrophages	NULL
were	NULL
stimulated	NULL
with	NULL
LPS	NULL
and	NULL
were	NULL
treated	NULL
with	NULL
PDTC	NULL
{	NULL
1	NULL
mmol/L	NULL
)	NULL
at	NULL
t	NULL
=	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
or	NULL
3	NULL
hours	NULL
and	NULL
then	NULL
pelletted	NULL
at	NULL
t	NULL
=	NULL
4	NULL
hours	NULL
for	NULL
later	NULL
measurement	NULL
of	NULL
PCA	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
four	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

*	NULL
P	NULL
<	NULL
.05	NULL
v	NULL
LPS	NULL
alone	NULL
;	NULL
**P	NULL
<	NULL
.05	NULL
v	NULL
medium	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1028	NULL
1000	NULL
--	NULL
*	NULL
200	NULL
+	NULL
Boo	NULL
+	NULL
700	NULL
+	NULL
eo0	NULL
+	NULL
400	NULL
+	NULL
300	NULL
+	NULL
200	NULL
+	NULL
**	NULL
``	NULL
1	NULL
CG	NULL
$	NULL
Medium	NULL
LPS	NULL
PCA	NULL
(	NULL
mU/10°	NULL
MS	NULL
)	NULL
g	NULL
Stimulus	NULL
Fig	NULL
3	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
LPS-induced	NULL
PCA	NULL
.	NULL

Murine	NULL
macrophages	NULL
were	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
pelletted	NULL
,	NULL
frozen	NULL
,	NULL
and	NULL
assayed	NULL
later	NULL
for	NULL
PCA	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
six	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

*P	NULL
<	NULL
.01	NULL
v	NULL
medium	NULL
alone	NULL
;	NULL
**P	NULL
<	NULL
.01	NULL
v	NULL
LPS	NULL
alone	NULL
.	NULL

(	NULL
D	NULL
}	NULL
Medium	NULL
;	NULL
(	NULL
&	NULL
)	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
)	NULL
.	NULL

PDTC	NULL
or	NULL
NAC	NULL
.	NULL

These	NULL
antioxidants	NULL
were	NULL
present	NULL
during	NULL
the	NULL
45-minute	NULL
preincubation	NULL
period	NULL
and	NULL
remained	NULL
present	NULL
during	NULL
the	NULL
subsequent	NULL
incubation	NULL
.	NULL

Addition	NULL
of	NULL
these	NULL
agents	NULL
at	NULL
the	NULL
time	NULL
of	NULL
stimulation	NULL
with	NULL
either	NULL
LPS	NULL
or	NULL
zymosan	NULL
gave	NULL
similar	NULL
results	NULL
.	NULL

Changes	NULL
in	NULL
chemiluminescence	NULL
were	NULL
recorded	NULL
over	NULL
a	NULL
4-hour	NULL
period	NULL
.	NULL

Relative	NULL
total	NULL
oxidant	NULL
production	NULL
was	NULL
obtained	NULL
by	NULL
integrating	NULL
the	NULL
area	NULL
under	NULL
the	NULL
chemiluminescence	NULL
curves	NULL
.	NULL

TF	NULL
and	NULL
TNF	NULL
mRNA	NULL
.	NULL

In	NULL
murine	NULL
macrophages	NULL
,	NULL
TF	NULL
and	NULL
TNF	NULL
mRNA	NULL
was	NULL
assessed	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
the	NULL
cDNA	NULL
probe	NULL
for	NULL
murine	NULL
TF	NULL
!	NULL

(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Michael	NULL
Getz	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
)	NULL
or	NULL
the	NULL
cDNA	NULL
probe	NULL
for	NULL
murine	NULL
TNF	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Bruce	NULL
Beutler	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
using	NULL
the	NULL
method	NULL
of	NULL
Chomezynski	NULL
and	NULL
Sacchi	NULL
.	NULL
``	NULL

After	NULL
electrophoresis	NULL
,	NULL
RNA	NULL
was	NULL
transferred	NULL
to	NULL
Immobilon	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
°P	NULL
random-labeled	NULL
cDNA	NULL
probe	NULL
for	NULL
murine	NULL
TF	NULL
or	NULL
murine	NULL
TNF	NULL
.	NULL

Comparable	NULL
RNA	NULL
loading	NULL
between	NULL
lanes	NULL
was	NULL
assured	NULL
by	NULL
probing	NULL
with	NULL
a	NULL
cDNA	NULL
probe	NULL
for	NULL
rat	NULL
-tubulin	NULL
(	NULL
provided	NULL
by	NULL
Dr	NULL
Dan	NULL
Drucker	NULL
,	NULL
University	NULL
of	NULL
Toronto	NULL
,	NULL
Toronto	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL
``	NULL

For	NULL
detection	NULL
of	NULL
human	NULL
TF	NULL
mRNA	NULL
or	NULL
TNF	NULL
mRNA	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
human	NULL
PBM	NULL
cells	NULL
and	NULL
,	NULL
after	NULL
electrophoresis	NULL
and	NULL
transfer	NULL
to	NULL
Immobilon	NULL
,	NULL
was	NULL
hybridized	NULL
with	NULL
the	NULL
°P	NULL
random-labeled	NULL
cDNA	NULL
probe	NULL
for	NULL
human	NULL
TF	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
[	NULL
ATCC	NULL
]	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
)	NULL
or	NULL
the	NULL
°P	NULL
random-labeled	NULL
cDNA	NULL
probe	NULL
for	NULL
human	NULL
TNF	NULL
(	NULL
ATCC	NULL
)	NULL
.	NULL

Densitometry	NULL
was	NULL
used	NULL
to	NULL
compare	NULL
the	NULL
relative	NULL
intensities	NULL
of	NULL
the	NULL
hybridization	NULL
signals	NULL
in	NULL
studies	NULL
investigating	NULL
the	NULL
levels	NULL
of	NULL
murine	NULL
TF	NULL
transcripts	NULL
.	NULL

Endotoxin	NULL
contamination	NULL
.	NULL

_	NULL
RPMI-1640	NULL
,	NULL
HBSS	NULL
,	NULL
sterile	NULL
water	NULL
,	NULL
and	NULL
sterile	NULL
saline	NULL
were	NULL
tested	NULL
for	NULL
endotoxin	NULL
contamination	NULL
using	NULL
the	NULL
standard	NULL
Limulus	NULL
amoebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
Association	NULL
of	NULL
Cape	NULL
Cod	NULL
,	NULL
Woods	NULL
Hole	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
less	NULL
than	NULL
0.1	NULL
ng	NULL
of	NULL
endotoxin	NULL
per	NULL
milliliter	NULL
,	NULL
which	NULL
constituted	NULL
the	NULL
lower	NULL
limit	NULL
of	NULL
the	NULL
test	NULL
.	NULL

Statistics	NULL
.	NULL

-	NULL
Statistics	NULL
were	NULL
calculated	NULL
using	NULL
one-way	NULL
analysis	NULL
of	NULL
variance	NULL
and	NULL
Neumann-Keuls	NULL
for	NULL
comparison	NULL
between	NULL
groups	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
and	NULL
standard	NULL
error	NULL
of	NULL
n	NULL
observations	NULL
.	NULL

RESULTS	NULL
Antioxidant	NULL
effects	NULL
of	NULL
PDTC	NULL
and	NULL
NAC	NULL
.	NULL

-	NULL
Two	NULL
antioxidants	NULL
with	NULL
different	NULL
mechanisms	NULL
of	NULL
action	NULL
were	NULL
studied	NULL
.	NULL

PDTC	NULL
BRISSEAU	NULL
ET	NULL
AL	NULL
is	NULL
an	NULL
oxygen	NULL
radical	NULL
scavenger	NULL
,	NULL
``	NULL
whereas	NULL
NAC	NULL
augments	NULL
endogenous	NULL
cellular	NULL
antioxidant	NULL
activity	NULL
by	NULL
increasing	NULL
levels	NULL
of	NULL
reduced	NULL
glutathione	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
The	NULL
ability	NULL
of	NULL
PDTC	NULL
and	NULL
NAC	NULL
to	NULL
abrogate	NULL
luminol-dependent	NULL
chemiluminescence	NULL
was	NULL
used	NULL
to	NULL
examine	NULL
their	NULL
antioxidant	NULL
activity	NULL
.	NULL

Both	NULL
agents	NULL
markedly	NULL
reduced	NULL
the	NULL
chemiluminescent	NULL
response	NULL
to	NULL
LPS	NULL
stimulation	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

The	NULL
inset	NULL
of	NULL
Fig	NULL
1	NULL
shows	NULL
the	NULL
mean	NULL
of	NULL
the	NULL
area	NULL
under	NULL
the	NULL
curve	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Effect	NULL
of	NULL
antioxidants	NULL
on	NULL
PCA	NULL
.	NULL

-	NULL
Having	NULL
defined	NULL
their	NULL
antioxidant	NULL
properties	NULL
,	NULL
these	NULL
molecules	NULL
were	NULL
tested	NULL
for	NULL
their	NULL
effect	NULL
on	NULL
LPS-induced	NULL
PCA	NULL
.	NULL

PDTC	NULL
caused	NULL
a	NULL
dose-dependent	NULL
inhibition	NULL
of	NULL
PCA	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
LPS	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
,	NULL
without	NULL
affecting	NULL
cell	NULL
viability	NULL
(	NULL
>	NULL
95	NULL
%	NULL
viability	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
)	NULL
.	NULL

The	NULL
IC	NULL
,	NULL
,	NULL
for	NULL
PDTC	NULL
was	NULL
approximately	NULL
77	NULL
mol/L	NULL
and	NULL
reached	NULL
almost	NULL
complete	NULL
inhibition	NULL
at	NULL
5	NULL
mmol/	NULL
L	NULL
PDTC	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
basal	NULL
levels	NULL
of	NULL
PCA	NULL
.	NULL

Neither	NULL
pyrrolidine	NULL
nor	NULL
pyroglutamic	NULL
acid	NULL
,	NULL
a	NULL
cyclic	NULL
molecule	NULL
resembling	NULL
PDTC	NULL
but	NULL
without	NULL
radical	NULL
scavenging	NULL
properties	NULL
,	NULL
was	NULL
able	NULL
to	NULL
mimick	NULL
the	NULL
effect	NULL
.	NULL

PDTC	NULL
added	NULL
to	NULL
the	NULL
functional	NULL
PCA	NULL
assay	NULL
also	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
clotting	NULL
time	NULL
reductions	NULL
induced	NULL
by	NULL
rabbit	NULL
brain	NULL
thromboplastin	NULL
or	NULL
cell-associated	NULL
TF	NULL
induced	NULL
by	NULL
4	NULL
hours	NULL
of	NULL
preincubation	NULL
with	NULL
LPS	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
time	NULL
course	NULL
of	NULL
PCA	NULL
induction	NULL
showed	NULL
that	NULL
PDTC	NULL
exhibited	NULL
inhibitory	NULL
effects	NULL
starting	NULL
at	NULL
2	NULL
hours	NULL
,	NULL
a	NULL
time	NULL
point	NULL
at	NULL
which	NULL
functional	NULL
PCA	NULL
activity	NULL
first	NULL
became	NULL
evident	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

Figure	NULL
2C	NULL
illustrates	NULL
the	NULL
effect	NULL
of	NULL
delayed	NULL
addition	NULL
of	NULL
PDTC	NULL
on	NULL
PCA	NULL
expression	NULL
by	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
PDTC	NULL
more	NULL
than	NULL
2	NULL
hours	NULL
after	NULL
treatment	NULL
with	NULL
LPS	NULL
resulted	NULL
in	NULL
a	NULL
reversal	NULL
of	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
PDTC	NULL
.	NULL

The	NULL
inhibitory	NULL
effect	NULL
was	NULL
not	NULL
unique	NULL
for	NULL
LPS-induced	NULL
PCA	NULL
,	NULL
because	NULL
PDTC	NULL
also	NULL
inhibited	NULL
the	NULL
stimulation	NULL
of	NULL
PCA	NULL
by	NULL
the	NULL
fungal	NULL
cell	NULL
wall	NULL
component	NULL
,	NULL
zymosan	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Disulfiram	NULL
,	NULL
which	NULL
has	NULL
antioxidant	NULL
properties	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
PDTC	NULL
,	NULL
effected	NULL
a	NULL
comparable	NULL
reduction	NULL
in	NULL
LPS-induced	NULL
PCA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
noted	NULL
in	NULL
the	NULL
previous	NULL
section	NULL
,	NULL
NAC	NULL
exerts	NULL
its	NULL
antioxidant	NULL
effect	NULL
by	NULL
increasing	NULL
levels	NULL
of	NULL
the	NULL
endogenous	NULL
antioxi-dant	NULL
,	NULL
reduced	NULL
glutathione	NULL
.	NULL

Figure	NULL
3	NULL
illustrates	NULL
the	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
PCA	NULL
induction	NULL
by	NULL
LPS	NULL
.	NULL

NAC	NULL
inhibited	NULL
PCA	NULL
at	NULL
30	NULL
mmol/L	NULL
,	NULL
a	NULL
concentration	NULL
shown	NULL
to	NULL
cause	NULL
a	NULL
fivefold	NULL
increase	NULL
in	NULL
intracellular	NULL
glutathione	NULL
levels	NULL
over	NULL
4	NULL
hours	NULL
of	NULL
incubation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
reduced	NULL
absolute	NULL
level	NULL
of	NULL
PCA	NULL
in	NULL
NAC-treated	NULL
LPS	NULL
cells	NULL
,	NULL
the	NULL
fold	NULL
increase	NULL
after	NULL
stimulation	NULL
with	NULL
LPS	NULL
was	NULL
comparable	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
NAC	NULL
(	NULL
10.6-fold	NULL
v	NULL
9.3-fold	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Viability	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
was	NULL
greater	NULL
than	NULL
94	NULL
%	NULL
.	NULL

Effect	NULL
of	NULL
antioxidants	NULL
on	NULL
TF	NULL
mRNA	NULL
levels	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
LPS-induced	NULL
PCA	NULL
in	NULL
macrophages	NULL
was	NULL
caused	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
TF	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

``	NULL
*	NULL
This	NULL
increase	NULL
required	NULL
new	NULL
RNA	NULL
and	NULL
protein	NULL
synthesis	NULL
.	NULL
``	NULL

Because	NULL
antioxidants	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
prevent	NULL
agonist-induced	NULL
gene	NULL
transcription	NULL
by	NULL
virtue	NULL
of	NULL
their	NULL
ability	NULL
to	NULL
inhibit	NULL
translocation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-kB	NULL
into	NULL
the	NULL
nucleus	NULL
,	NULL
``	NULL
it	NULL
was	NULL
hypothesized	NULL
that	NULL
PDTC	NULL
and	NULL
NAC	NULL
might	NULL
inhibit	NULL
TF	NULL
expression	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
.	NULL

Northern	NULL
analysis	NULL
was	NULL
performed	NULL
to	NULL
assess	NULL
TF	NULL
mRNA	NULL
levels	NULL
in	NULL
LPS-treated	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
antioxidants	NULL
.	NULL

Similar	NULL
to	NULL
findings	NULL
reported	NULL
for	NULL
human	NULL
monocytes	NULL
,	NULL
``	NULL
LPS	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
TF	NULL
mRNA	NULL
in	NULL
murine	NULL
macrophages	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ANTIOXIDANTS	NULL
AND	NULL
MACROPHAGE	NULL
TISSUE	NULL
FACTOR	NULL
A	NULL
Tissue	NULL
Factor	NULL
-	NULL
'	NULL
.	NULL

«	NULL
Tubulin	NULL
-	NULL
>	NULL
LPS	NULL
PDTC	NULL
&	NULL
~I	NULL
i	NULL
1	NULL
Relative	NULL
Density	NULL
J	NULL
no	NULL
LPS	NULL
LPS	NULL
1029	NULL
Tissue	NULL
Factor	NULL
«	NULL
Tubulin	NULL
-	NULL
>	NULL
coy	NULL
NAC	NULL
__	NULL
-	NULL
_-	NULL
+	NULL
+	NULL
O	NULL
8	NULL
3	NULL
7	NULL
+	NULL
[	NULL
___	NULL
]	NULL
no	NULL
NAC	NULL
R	NULL
nac	NULL
4__	NULL
3..-	NULL
Relative	NULL
Density	NULL
no	NULL
LPS	NULL
LPS	NULL
Fig	NULL
4	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
(	NULL
A	NULL
)	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
)	NULL
or	NULL
(	NULL
C	NULL
)	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
)	NULL
on	NULL
LPS-induced	NULL
levels	NULL
of	NULL
TF	NULL
mRNA	NULL
.	NULL

The	NULL
antioxidant	NULL
was	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
as	NULL
indicated	NULL
for	NULL
4	NULL
hours	NULL
and	NULL
Northern	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
either	NULL
the	NULL
cDNA	NULL
probe	NULL
for	NULL
murine	NULL
TF	NULL
or	NULL
rat	NULL
-tubulin	NULL
.	NULL

A	NULL
representative	NULL
blot	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
and	NULL
(	NULL
D	NULL
)	NULL
show	NULL
the	NULL
mean	NULL
intensities	NULL
(	NULL
+SEM	NULL
)	NULL
normalized	NULL
for	NULL
loading	NULL
for	NULL
PDTC	NULL
(	NULL
n	NULL
=	NULL
4	NULL
independent	NULL
studies	NULL
)	NULL
and	NULL
NAC	NULL
(	NULL
n	NULL
=	NULL
3	NULL
independent	NULL
studies	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
Fig	NULL
4	NULL
;	NULL
mean	NULL
fold	NULL
increase	NULL
when	NULL
normalized	NULL
for	NULL
loading	NULL
:	NULL
5.2	NULL
%	NULL
;	NULL
n	NULL
=	NULL
7	NULL
separate	NULL
experiments	NULL
)	NULL
.	NULL

However	NULL
,	NULL
neither	NULL
PDTC	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
nor	NULL
NAC	NULL
(	NULL
Fig	NULL
4C	NULL
)	NULL
prevented	NULL
this	NULL
LPS-stimulated	NULL
increase	NULL
.	NULL

Figure	NULL
4B	NULL
and	NULL
D	NULL
illustrates	NULL
the	NULL
mean	NULL
intensities	NULL
of	NULL
the	NULL
hybridization	NULL
signals	NULL
normalized	NULL
for	NULL
loading	NULL
for	NULL
studies	NULL
performed	NULL
with	NULL
PDTC	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
and	NULL
NAC	NULL
(	NULL
n	NULL
=	NULL
3	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Effect	NULL
of	NULL
antioxidants	NULL
on	NULL
TF	NULL
expression	NULL
.	NULL

-	NULL
Immunofluo-resence	NULL
and	NULL
Western	NULL
blot	NULL
analysis	NULL
with	NULL
polyclonal	NULL
antihuman	NULL
TF	NULL
antibody	NULL
were	NULL
used	NULL
to	NULL
evaluate	NULL
posttranscriptional	NULL
alterations	NULL
in	NULL
TF	NULL
.	NULL

These	NULL
studies	NULL
were	NULL
performed	NULL
in	NULL
human	NULL
monocytes	NULL
because	NULL
of	NULL
the	NULL
availability	NULL
of	NULL
the	NULL
antihuman	NULL
TF	NULL
antibody	NULL
and	NULL
the	NULL
fact	NULL
that	NULL
others	NULL
have	NULL
documented	NULL
poor	NULL
cross-reactivity	NULL
with	NULL
rodent	NULL
TF	NULL
.	NULL

*	NULL
'	NULL
Figure	NULL
SA	NULL
shows	NULL
the	NULL
effect	NULL
of	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
)	NULL
on	NULL
PCA	NULL
in	NULL
human	NULL
monocytes	NULL
after	NULL
exposure	NULL
to	NULL
LPS	NULL
.	NULL

As	NULL
shown	NULL
for	NULL
murine	NULL
cells	NULL
,	NULL
NAC	NULL
markedly	NULL
reduced	NULL
LPS-induced	NULL
PCA	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
)	NULL
inhibited	NULL
LPS-stimulated	NULL
PCA	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

Human	NULL
monocytes	NULL
exposed	NULL
to	NULL
either	NULL
NAC	NULL
or	NULL
PDTC	NULL
for	NULL
4	NULL
hours	NULL
retained	NULL
their	NULL
ability	NULL
to	NULL
exclude	NULL
trypan	NULL
blue	NULL
(	NULL
>	NULL
95	NULL
%	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effect	NULL
was	NULL
not	NULL
caused	NULL
by	NULL
cytotoxicity	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
in	NULL
PCA	NULL
after	NULL
stimulation	NULL
with	NULL
LPS	NULL
was	NULL
also	NULL
higher	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
NAC	NULL
(	NULL
62-fold	NULL
)	NULL
than	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NAC	NULL
(	NULL
36-fold	NULL
)	NULL
,	NULL
further	NULL
showing	NULL
the	NULL
lack	NULL
of	NULL
cytotoxicity	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
level	NULL
of	NULL
TF	NULL
mRNA	NULL
transcripts	NULL
in	NULL
human	NULL
monocytes	NULL
was	NULL
similar	NULL
in	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
NAC	NULL
(	NULL
Fig	NULL
5C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
antioxidants	NULL
on	NULL
human	NULL
cells	NULL
appear	NULL
to	NULL
recapitulate	NULL
those	NULL
observed	NULL
in	NULL
murine	NULL
cells	NULL
,	NULL
thereby	NULL
justifying	NULL
further	NULL
study	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Immunofluorescence	NULL
studies	NULL
performed	NULL
on	NULL
permeabilized	NULL
human	NULL
cells	NULL
showed	NULL
that	NULL
TF	NULL
reactivity	NULL
was	NULL
markedly	NULL
in	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1030	NULL
2750	NULL
2000	NULL
1750	NULL
PCA	NULL
(	NULL
mU/10°	NULL
Mo	NULL
)	NULL
»	NULL
o	NULL
Bg	NULL
¢	NULL
§	NULL
§	NULL
8	NULL
LPS	NULL
Stimulus	NULL
Medium	NULL
+	NULL
+	NULL
creased	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
in	NULL
LPS-treated	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
controls	NULL
no	NULL
distinct	NULL
reactivity	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
consistent	NULL
with	NULL
previous	NULL
observa-tions	NULL
.	NULL
``	NULL

NAC	NULL
completely	NULL
prevented	NULL
the	NULL
plasmalemmal	NULL
localization	NULL
of	NULL
antigen	NULL
in	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
and	NULL
cells	NULL
appeared	NULL
similar	NULL
to	NULL
controls	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
effect	NULL
in	NULL
further	NULL
detail	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
used	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

LPS-treated	NULL
cells	NULL
exhibited	NULL
a	NULL
large	NULL
increase	NULL
in	NULL
a	NULL
band	NULL
with	NULL
approximate	NULL
molecular	NULL
mass	NULL
of	NULL
47	NULL
kD	NULL
,	NULL
consistent	NULL
with	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
mature	NULL
fully	NULL
glycosylated	NULL
TF	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
a	NULL
band	NULL
at	NULL
33	NULL
kD	NULL
.	NULL

This	NULL
result	NULL
likely	NULL
represents	NULL
the	NULL
unglycosylated	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
.	NULL
``	NULL

The	NULL
addition	NULL
of	NULL
NAC	NULL
during	NULL
stimulation	NULL
with	NULL
LPS	NULL
completely	NULL
prevented	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
high	NULL
molecular	NULL
mass	NULL
band	NULL
and	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
band	NULL
at	NULL
33	NULL
kD	NULL
.	NULL

NAC	NULL
alone	NULL
caused	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
band	NULL
at	NULL
33	NULL
BRISSEAU	NULL
ET	NULL
AL	NULL
&	NULL
*	NULL
2600	NULL
+	NULL
1	NULL
2400	NULL
1	NULL
2200	NULL
+	NULL
2000	NULL
1	NULL
1800	NULL
+	NULL
1600	NULL
+	NULL
1400	NULL
+	NULL
1200	NULL
+	NULL
1000	NULL
+	NULL
800	NULL
1+	NULL
600	NULL
+	NULL
400	NULL
1	NULL
200	NULL
+	NULL
PCA	NULL
(	NULL
mu/1x10°	NULL
mo	NULL
)	NULL
%	NULL
%	NULL
mm	NULL
_	NULL
LPS	NULL
(	NULL
10ug/mi	NULL
)	NULL
no	NULL
LPS	NULL
Fig	NULL
5	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
NAC	NULL
on	NULL
LPS-induced	NULL
PCA	NULL
in	NULL
human	NULL
PBM	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
g/mL	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
pelletted	NULL
and	NULL
frozen	NULL
for	NULL
later	NULL
PCA	NULL
assay	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

*P	NULL
<	NULL
.01	NULL
v	NULL
medium	NULL
alone	NULL
;	NULL
**P	NULL
<	NULL
.01	NULL
v	NULL
LPS	NULL
alone	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Medium	NULL
;	NULL
(	NULL
#	NULL
)	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
)	NULL
on	NULL
LPS-induced	NULL
PCA	NULL
in	NULL
human	NULL
PBM	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
mg/mL	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
pelletted	NULL
and	NULL
frozen	NULL
for	NULL
later	NULL
PCA	NULL
assay	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

*P	NULL
<	NULL
.01	NULL
v	NULL
medium	NULL
alone	NULL
;	NULL
**P	NULL
<	NULL
.01	NULL
v	NULL
LPS	NULL
alone	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Medium	NULL
;	NULL
(	NULL
M	NULL
)	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
effect	NULL
of	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
)	NULL
on	NULL
LPS-induced	NULL
levels	NULL
of	NULL
TF	NULL
mRNA	NULL
in	NULL
human	NULL
PBM	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
as	NULL
indicated	NULL
for	NULL
4	NULL
hours	NULL
and	NULL
Northern	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
either	NULL
the	NULL
cDNA	NULL
probe	NULL
for	NULL
human	NULL
TF	NULL
or	NULL
-tubulin	NULL
.	NULL

The	NULL
blot	NULL
illustrated	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
studies	NULL
.	NULL

kD	NULL
.	NULL

There	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
degraded	NULL
immunoreactive	NULL
TF	NULL
in	NULL
NAC-treated	NULL
cells	NULL
.	NULL

Incubation	NULL
of	NULL
preformed	NULL
TF	NULL
with	NULL
NAC	NULL
also	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
reactivity	NULL
of	NULL
the	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Release	NULL
of	NULL
TNF	NULL
by	NULL
LPS-treated	NULL
cells	NULL
.	NULL

To	NULL
discern	NULL
whether	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
PDTC	NULL
and	NULL
NAC	NULL
on	NULL
TF	NULL
expression	NULL
was	NULL
caused	NULL
by	NULL
a	NULL
global	NULL
effect	NULL
on	NULL
protein	NULL
synthesis	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
these	NULL
antioxidant	NULL
molecules	NULL
on	NULL
release	NULL
of	NULL
TNF	NULL
was	NULL
studied	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
8A	NULL
,	NULL
PDTC	NULL
augmented	NULL
LPS-stimulated	NULL
TNF	NULL
release	NULL
from	NULL
murine	NULL
macrophages	NULL
,	NULL
whereas	NULL
PDTC	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
basal	NULL
TNF	NULL
levels	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
NAC	NULL
did	NULL
not	NULL
alter	NULL
either	NULL
basal	NULL
or	NULL
LPS-stimulated	NULL
TNF	NULL
release	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
showed	NULL
that	NULL
PDTC	NULL
augmented	NULL
TNF	NULL
mRNA	NULL
accumulation	NULL
in	NULL
LPS-treated	NULL
murine	NULL
cells	NULL
,	NULL
over	NULL
the	NULL
time	NULL
course	NULL
of	NULL
augmented	NULL
TNF	NULL
release	NULL
(	NULL
Fig	NULL
9A	NULL
)	NULL
.	NULL

How	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ANTIOXIDANTS	NULL
AND	NULL
MACROPHAGE	NULL
TISSUE	NULL
FACTOR	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
Immunofluorescence	NULL
of	NULL
human	NULL
monocytes	NULL
using	NULL
antihuman	NULL
TF	NULL
antibody	NULL
.	NULL

Cells	NULL
were	NULL
adhered	NULL
to	NULL
glass	NULL
coverslips	NULL
and	NULL
treated	NULL
for	NULL
4	NULL
hours	NULL
with	NULL
(	NULL
A	NULL
)	NULL
medium	NULL
alone	NULL
,	NULL
(	NULL
B	NULL
)	NULL
NAC	NULL
alone	NULL
,	NULL
(	NULL
C	NULL
)	NULL
LPS	NULL
alone	NULL
,	NULL
or	NULL
(	NULL
D	NULL
)	NULL
LPS	NULL
plus	NULL
NAC	NULL
(	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
fixed	NULL
,	NULL
permeabilized	NULL
,	NULL
stained	NULL
,	NULL
and	NULL
viewed	NULL
as	NULL
outlined	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
representative	NULL
study	NULL
of	NULL
two	NULL
independent	NULL
studies	NULL
is	NULL
shown	NULL
.	NULL

ever	NULL
,	NULL
PDTC	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

Figure	NULL
9B	NULL
shows	NULL
a	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
PDTC	NULL
on	NULL
LPS-induced	NULL
TNF	NULL
mRNA	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
murine	NULL
cells	NULL
,	NULL
PDTC	NULL
reduced	NULL
levels	NULL
of	NULL
TNF	NULL
mRNA	NULL
in	NULL
human	NULL
cells	NULL
exposed	NULL
to	NULL
LPS	NULL
.	NULL

DISsCUSssIoON	NULL
Antioxidants	NULL
acting	NULL
by	NULL
two	NULL
distinct	NULL
mechanisms	NULL
inhibited	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
TF	NULL
in	NULL
LPS-	NULL
and	NULL
zymosan-treated	NULL
49	NULL
J	NULL
&	NULL
Lukes	NULL
;	NULL
LPS	NULL
-	NULL
+	NULL
NAC	NULL
-	NULL
1031	NULL
murine	NULL
macrophages	NULL
.	NULL

In	NULL
human	NULL
monocytes	NULL
,	NULL
one	NULL
of	NULL
these	NULL
agents	NULL
,	NULL
NAC	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
inhibit	NULL
both	NULL
the	NULL
functional	NULL
and	NULL
antigenic	NULL
expression	NULL
of	NULL
mature	NULL
TF	NULL
normally	NULL
induced	NULL
by	NULL
exposure	NULL
to	NULL
LPS	NULL
.	NULL

Inhibition	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
caused	NULL
by	NULL
cytotoxicity	NULL
or	NULL
a	NULL
nonspecific	NULL
effect	NULL
related	NULL
to	NULL
interference	NULL
with	NULL
the	NULL
assay	NULL
systems	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
both	NULL
compounds	NULL
exhibited	NULL
potent	NULL
antioxidant	NULL
activity	NULL
coupled	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
PDTC	NULL
was	NULL
ineffective	NULL
when	NULL
added	NULL
at	NULL
a	NULL
time	NULL
point	NULL
after	NULL
the	NULL
decline	NULL
of	NULL
LPS-induced	NULL
chemiluminescence	NULL
Fig	NULL
7	NULL
.	NULL

Western	NULL
analysis	NULL
of	NULL
TF	NULL
expression	NULL
in	NULL
human	NULL
PBM	NULL
cells	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
as	NULL
indicated	NULL
for	NULL
4	NULL
hours	NULL
,	NULL
solubilized	NULL
in	NULL
boiling	NULL
Laemmli	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
immunoblotting	NULL
as	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
polyclonal	NULL
antihuman	NULL
TF	NULL
antibody	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
shown	NULL
at	NULL
+	NULL
+	NULL
the	NULL
left	NULL
.	NULL

A	NULL
representative	NULL
blot	NULL
of	NULL
four	NULL
studies	NULL
is	NULL
shown	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1032	NULL
3	NULL
>	NULL
TNF	NULL
(	NULL
ng/ml	NULL
)	NULL
3	NULL
tee	NULL
o	NULL
1	NULL
Time	NULL
(	NULL
hr	NULL
)	NULL
1.50	NULL
1.25	NULL
1.00	NULL
0.75	NULL
0.50	NULL
TNF	NULL
(	NULL
ng/ml	NULL
)	NULL
0.25	NULL
0.00	NULL
LPS	NULL
Medium	NULL
Stimulus	NULL
Fig	NULL
8	NULL
.	NULL

Effect	NULL
of	NULL
PDTC	NULL
and	NULL
NAC	NULL
on	NULL
TNF	NULL
secretion	NULL
.	NULL

in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
murine	NULL
macrophages	NULL
were	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
LPS	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
)	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
supernatants	NULL
were	NULL
aspirated	NULL
and	NULL
used	NULL
for	NULL
TNF	NULL
assay	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
three	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

(	NULL
0	NULL
)	NULL
Medium	NULL
;	NULL
(	NULL
@	NULL
)	NULL
LPS	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
;	NULL
(	NULL
0	NULL
)	NULL
PDTC	NULL
{	NULL
1	NULL
mmol/L	NULL
)	NULL
;	NULL
(	NULL
M	NULL
)	NULL
LPS	NULL
+	NULL
PDTC	NULL
.	NULL

in	NULL
(	NULL
B	NULL
)	NULL
,	NULL
murine	NULL
macrophages	NULL
were	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
}	NULL
and	NULL
supernatant	NULL
was	NULL
aspirated	NULL
for	NULL
TNF	NULL
measurements	NULL
.	NULL

TNF	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
as	NULL
outlined	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
data	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
six	NULL
experiments	NULL
,	NULL
each	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

*P	NULL
<	NULL
.05	NULL
v	NULL
medium	NULL
at	NULL
same	NULL
time	NULL
point	NULL
;	NULL
**P	NULL
<	NULL
.05	NULL
v	NULL
LPS	NULL
alone	NULL
at	NULL
same	NULL
time	NULL
point	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Medium	NULL
;	NULL
(	NULL
&	NULL
)	NULL
NAC	NULL
(	NULL
30	NULL
mmol/L	NULL
)	NULL
.	NULL

(	NULL
t	NULL
=	NULL
3	NULL
hours	NULL
,	NULL
see	NULL
Fig	NULL
1	NULL
)	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
agents	NULL
exerted	NULL
their	NULL
effects	NULL
via	NULL
their	NULL
antioxidant	NULL
proper-ties	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
structural	NULL
analogues	NULL
of	NULL
PDTC	NULL
without	NULL
antioxidant	NULL
activity	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
TF	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
antioxidants	NULL
had	NULL
a	NULL
differential	NULL
effect	NULL
on	NULL
TNF	NULL
secretion	NULL
compared	NULL
with	NULL
TF	NULL
expression	NULL
in	NULL
murine	NULL
macrophages	NULL
.	NULL

Although	NULL
both	NULL
PDTC	NULL
and	NULL
NAC	NULL
inhibited	NULL
LPS-induced	NULL
TF	NULL
,	NULL
stimulated	NULL
TNF	NULL
release	NULL
BRISSEAU	NULL
ET	NULL
AL	NULL
was	NULL
either	NULL
comparable	NULL
or	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
NAC	NULL
and	NULL
PDTC	NULL
,	NULL
respectively	NULL
.	NULL

Inhibition	NULL
of	NULL
TF	NULL
expression	NULL
appeared	NULL
to	NULL
be	NULL
unrelated	NULL
to	NULL
alterations	NULL
in	NULL
gene	NULL
transcription	NULL
,	NULL
because	NULL
neither	NULL
agent	NULL
reduced	NULL
the	NULL
level	NULL
of	NULL
TF	NULL
gene	NULL
transcripts	NULL
compared	NULL
with	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
alone	NULL
in	NULL
either	NULL
the	NULL
murine	NULL
or	NULL
human	NULL
system	NULL
.	NULL

Rather	NULL
,	NULL
the	NULL
effect	NULL
appeared	NULL
to	NULL
be	NULL
posttranscriptional	NULL
.	NULL

Several	NULL
precedents	NULL
exist	NULL
whereby	NULL
the	NULL
redox	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
might	NULL
modulate	NULL
posttranscriptional	NULL
events	NULL
.	NULL

The	NULL
redox	NULL
state	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
alter	NULL
mRNA	NULL
stability	NULL
,	NULL
``	NULL
to	NULL
modulate	NULL
transla-tion	NULL
,	NULL
**	NULL
and	NULL
to	NULL
affect	NULL
posttranslational	NULL
modification	NULL
of	NULL
newly	NULL
synthesized	NULL
proteins	NULL
.	NULL
``	NULL

Finally	NULL
,	NULL
the	NULL
redox	NULL
potential	NULL
might	NULL
directly	NULL
affect	NULL
the	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
completely	NULL
processed	NULL
mature	NULL
protein	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
the	NULL
accumulation	NULL
of	NULL
mRNA	NULL
for	NULL
TF	NULL
in	NULL
LPS-treated	NULL
cells	NULL
was	NULL
equivalent	NULL
in	NULL
either	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
antioxidants	NULL
suggests	NULL
that	NULL
an	NULL
effect	NULL
on	NULL
mRNA	NULL
stability	NULL
is	NULL
unlikely	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
NAC	NULL
to	NULL
commercially	NULL
acquired	NULL
rabbit	NULL
brain	NULL
thromboplastin	NULL
or	NULL
to	NULL
presynthesized	NULL
cell-associated	NULL
TF	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
its	NULL
procoagulant	NULL
function	NULL
,	NULL
indicating	NULL
that	NULL
direct	NULL
reduction	NULL
of	NULL
the	NULL
active	NULL
glycoprotein	NULL
did	NULL
not	NULL
alter	NULL
function	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
the	NULL
antioxidants	NULL
directly	NULL
altered	NULL
the	NULL
activity	NULL
of	NULL
membrane-associated	NULL
TF	NULL
.	NULL

The	NULL
findings	NULL
are	NULL
more	NULL
consistent	NULL
with	NULL
either	NULL
reduced	NULL
translation	NULL
of	NULL
the	NULL
mRNA	NULL
or	NULL
some	NULL
posttranslational	NULL
alteration	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
TNF	NULL
release	NULL
was	NULL
normal	NULL
or	NULL
increased	NULL
in	NULL
LPS-treated	NULL
cells	NULL
exposed	NULL
to	NULL
both	NULL
antioxidants	NULL
indicates	NULL
that	NULL
the	NULL
transla-tional	NULL
machinery	NULL
remained	NULL
intact	NULL
despite	NULL
exposure	NULL
to	NULL
these	NULL
molecules	NULL
.	NULL

However	NULL
,	NULL
this	NULL
does	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
agents	NULL
might	NULL
have	NULL
a	NULL
specific	NULL
effect	NULL
on	NULL
the	NULL
translation	NULL
of	NULL
the	NULL
mRNA	NULL
for	NULL
TF	NULL
.	NULL

Although	NULL
Western	NULL
blot	NULL
analysis	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
LPS	NULL
plus	NULL
NAC	NULL
showed	NULL
no	NULL
evidence	NULL
of	NULL
the	NULL
fully	NULL
glycosylated	NULL
mature	NULL
form	NULL
of	NULL
TF	NULL
,	NULL
there	NULL
was	NULL
also	NULL
no	NULL
accumulation	NULL
of	NULL
the	NULL
less	NULL
mature	NULL
forms	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
consistent	NULL
with	NULL
reduced	NULL
translation	NULL
and/or	NULL
degradation	NULL
of	NULL
the	NULL
newly	NULL
translated	NULL
protein	NULL
,	NULL
a	NULL
phenomenon	NULL
that	NULL
likely	NULL
occurred	NULL
within	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
(	NULL
ER	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
stability	NULL
of	NULL
proteins	NULL
retained	NULL
in	NULL
the	NULL
ER	NULL
was	NULL
sensitive	NULL
to	NULL
redox	NULL
conditions	NULL
.	NULL
``	NULL

Specifically	NULL
,	NULL
induction	NULL
of	NULL
reducing	NULL
conditions	NULL
within	NULL
the	NULL
ER	NULL
promoted	NULL
protein	NULL
degradation	NULL
.	NULL

These	NULL
investigators	NULL
showed	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
reduced	NULL
glutathione	NULL
to	NULL
permeabilized	NULL
CHO	NULL
cells	NULL
caused	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
the	NULL
half-life	NULL
of	NULL
IL-2	NULL
receptor	NULL
in	NULL
the	NULL
ER	NULL
.	NULL

The	NULL
mechanism	NULL
behind	NULL
this	NULL
reduction	NULL
is	NULL
unclear	NULL
,	NULL
although	NULL
reduction	NULL
of	NULL
disulfide	NULL
bonds	NULL
formed	NULL
in	NULL
the	NULL
normally	NULL
oxidizing	NULL
conditions	NULL
in	NULL
the	NULL
ER	NULL
may	NULL
lead	NULL
to	NULL
unfolding	NULL
of	NULL
proteins	NULL
,	NULL
retention	NULL
in	NULL
the	NULL
ER	NULL
,	NULL
and	NULL
enhanced	NULL
degradation	NULL
.	NULL

*	NULL
``	NULL
*	NULL
``	NULL
In	NULL
this	NULL
regard	NULL
,	NULL
two	NULL
disulfide	NULL
bonds	NULL
(	NULL
between	NULL
Cys-49	NULL
and	NULL
Cys-57	NULL
and	NULL
between	NULL
Cys-186	NULL
and	NULL
Cys-209	NULL
)	NULL
exist	NULL
within	NULL
the	NULL
extracellular	NULL
domain	NULL
of	NULL
TF	NULL
.	NULL
``	NULL

Prevention	NULL
of	NULL
disulfide	NULL
linkages	NULL
by	NULL
altering	NULL
the	NULL
redox	NULL
state	NULL
of	NULL
the	NULL
cell	NULL
may	NULL
underlie	NULL
the	NULL
effect	NULL
of	NULL
antioxidants	NULL
on	NULL
TF	NULL
expression	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
TF	NULL
,	NULL
TNF	NULL
secretion	NULL
was	NULL
unaffected	NULL
by	NULL
NAC	NULL
.	NULL

This	NULL
observation	NULL
may	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
the	NULL
absolute	NULL
or	NULL
relative	NULL
resistance	NULL
of	NULL
some	NULL
proteins	NULL
to	NULL
proteo-lytic	NULL
degradation	NULL
by	NULL
ER	NULL
proteases	NULL
,	NULL
even	NULL
under	NULL
reducing	NULL
conditions	NULL
.	NULL
``	NULL

Alternatively	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
TNF	NULL
contains	NULL
only	NULL
one	NULL
disulfide	NULL
bond	NULL
may	NULL
account	NULL
for	NULL
its	NULL
resistance	NULL
compared	NULL
with	NULL
TF	NULL
.	NULL
``	NULL

This	NULL
differential	NULL
effect	NULL
may	NULL
be	NULL
similar	NULL
to	NULL
that	NULL
reported	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ANTIOXIDANTS	NULL
AND	NULL
MACROPHAGE	NULL
TISSUE	NULL
FACTOR	NULL
A	NULL
TNF	NULL
&	NULL
Tubulin	NULL
-	NULL
>	NULL
-	NULL
ewig	NULL
usu	NULL
LPS	NULL
PDTC	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
1033	NULL
TNF	NULL
-	NULL
>	NULL
#	NULL
-	NULL
e	NULL
Tubulin	NULL
LPS	NULL
_-	NULL
+	NULL
-	NULL
+	NULL
PDTC	NULL
_-	NULL
-	NULL
+	NULL
+	NULL
Fig	NULL
9	NULL
.	NULL

Effect	NULL
of	NULL
PDTC	NULL
on	NULL
levels	NULL
of	NULL
TNF	NULL
mRNA	NULL
in	NULL
murine	NULL
macrophages	NULL
(	NULL
A	NULL
)	NULL
or	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Murine	NULL
macrophages	NULL
or	NULL
human	NULL
monocytes	NULL
were	NULL
unstimulated	NULL
or	NULL
treated	NULL
with	NULL
LPS	NULL
(	NULL
10	NULL
pg/mL	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PDTC	NULL
(	NULL
1	NULL
mmol/L	NULL
added	NULL
at	NULL
t	NULL
=	NULL
0	NULL
hour	NULL
)	NULL
for	NULL
4	NULL
hours	NULL
.	NULL

Levels	NULL
of	NULL
TNF	NULL
and	NULL
«	NULL
-tubulin	NULL
mRNA	NULL
were	NULL
evaluated	NULL
by	NULL
Northern	NULL
analysis	NULL
using	NULL
the	NULL
cDNA	NULL
probe	NULL
for	NULL
murine	NULL
TNF	NULL
or	NULL
human	NULL
TNF	NULL
and	NULL
rat	NULL
a-tubulin	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

A	NULL
representative	NULL
blot	NULL
of	NULL
three	NULL
(	NULL
A	NULL
)	NULL
or	NULL
six	NULL
(	NULL
B	NULL
)	NULL
independent	NULL
studies	NULL
is	NULL
illustrated	NULL
.	NULL

by	NULL
Lentz	NULL
and	NULL
Sadler®	NULL
showing	NULL
that	NULL
homocysteine	NULL
caused	NULL
retention	NULL
of	NULL
the	NULL
immature	NULL
form	NULL
of	NULL
von	NULL
Willebrand	NULL
factor	NULL
within	NULL
the	NULL
ER	NULL
of	NULL
endothelial	NULL
cells	NULL
with	NULL
subsequent	NULL
degrada-tion	NULL
,	NULL
whereas	NULL
plasminogen	NULL
activator	NULL
inhibitor-1	NULL
was	NULL
normally	NULL
secreted	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
define	NULL
the	NULL
precise	NULL
mechanism	NULL
of	NULL
the	NULL
effect	NULL
observed	NULL
in	NULL
the	NULL
present	NULL
studies	NULL
.	NULL

In	NULL
human	NULL
monocytes	NULL
,	NULL
NAC	NULL
reduced	NULL
LPS-induced	NULL
expression	NULL
of	NULL
the	NULL
47-kD	NULL
form	NULL
of	NULL
TF	NULL
almost	NULL
back	NULL
to	NULL
control	NULL
levels	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
mean	NULL
reduction	NULL
in	NULL
functional	NULL
activity	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
NAC	NULL
was	NULL
approximately	NULL
65	NULL
%	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
neutralizing	NULL
studies	NULL
using	NULL
antihuman	NULL
TF	NULL
antibody	NULL
,	NULL
the	NULL
residual	NULL
procoagulant	NULL
activity	NULL
was	NULL
almost	NULL
entirely	NULL
caused	NULL
by	NULL
TF	NULL
activity	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
the	NULL
mean	NULL
functional	NULL
activity	NULL
from	NULL
several	NULL
experiments	NULL
and	NULL
the	NULL
TF	NULL
antigen	NULL
expression	NULL
shown	NULL
in	NULL
the	NULL
single	NULL
Western	NULL
blot	NULL
study	NULL
NAC-treated	NULL
cells	NULL
is	NULL
caused	NULL
by	NULL
day-to-day	NULL
variability	NULL
in	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
NAC	NULL
.	NULL

The	NULL
Western	NULL
blot	NULL
shown	NULL
in	NULL
Fig	NULL
7	NULL
corresponds	NULL
to	NULL
an	NULL
experiment	NULL
in	NULL
which	NULL
there	NULL
was	NULL
an	NULL
89	NULL
%	NULL
reduction	NULL
in	NULL
functional	NULL
PCA	NULL
after	NULL
NAC	NULL
treatment	NULL
.	NULL

ROS	NULL
have	NULL
been	NULL
implicated	NULL
as	NULL
second	NULL
messengers	NULL
during	NULL
cell	NULL
activation	NULL
.	NULL

Direct	NULL
application	NULL
of	NULL
oxidant	NULL
molecules	NULL
or	NULL
other	NULL
oxidant	NULL
stresses	NULL
induces	NULL
translocation	NULL
of	NULL
transcriptional	NULL
activating	NULL
factors	NULL
such	NULL
as	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
into	NULL
the	NULL
nucleus	NULL
and	NULL
the	NULL
initiation	NULL
of	NULL
gene	NULL
transcription	NULL
.	NULL

*	NULL
'	NULL
``	NULL
Incubation	NULL
with	NULL
antioxidants	NULL
during	NULL
cell	NULL
stimulation	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
prevent	NULL
DNA	NULL
binding	NULL
and	NULL
transcriptional	NULL
activation	NULL
by	NULL
NF-kB	NULL
for	NULL
some	NULL
genes	NULL
,	NULL
``	NULL
``	NULL
``	NULL
*	NULL
``	NULL
but	NULL
not	NULL
for	NULL
others	NULL
.	NULL
``	NULL

''	NULL
Furthermore	NULL
,	NULL
in	NULL
a	NULL
somewhat	NULL
paradoxical	NULL
fashion	NULL
,	NULL
antioxidants	NULL
such	NULL
as	NULL
PDTC	NULL
and	NULL
NAC	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
have	NULL
a	NULL
stimulatory	NULL
effect	NULL
on	NULL
transactivation	NULL
by	NULL
AP-1	NULL
.	NULL
``	NULL

In	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
both	NULL
PDTC	NULL
and	NULL
NAC	NULL
caused	NULL
a	NULL
slight	NULL
increase	NULL
in	NULL
the	NULL
LPS-induced	NULL
increase	NULL
in	NULL
levels	NULL
of	NULL
TF	NULL
mRNA	NULL
in	NULL
murine	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
NAC	NULL
alone	NULL
caused	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
TF	NULL
mRNA	NULL
transcripts	NULL
in	NULL
murine	NULL
cells	NULL
,	NULL
although	NULL
this	NULL
was	NULL
not	NULL
observed	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Because	NULL
binding	NULL
of	NULL
both	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
consensus	NULL
sequences	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
TF	NULL
gene	NULL
participate	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
TF	NULL
gene	NULL
transcription	NULL
,	NULL
``	NULL
``	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
increased	NULL
AP-1	NULL
binding	NULL
may	NULL
have	NULL
accounted	NULL
for	NULL
the	NULL
direct	NULL
effect	NULL
of	NULL
NAC	NULL
and	NULL
also	NULL
may	NULL
have	NULL
acted	NULL
to	NULL
compensate	NULL
for	NULL
the	NULL
antioxidant-mediated	NULL
reduction	NULL
in	NULL
NF-KB	NULL
binding	NULL
in	NULL
LPS-treated	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
no	NULL
overall	NULL
alteration	NULL
in	NULL
the	NULL
level	NULL
of	NULL
TF	NULL
transcripts	NULL
.	NULL

PDTC	NULL
increased	NULL
the	NULL
level	NULL
of	NULL
TNF	NULL
mRNA	NULL
and	NULL
the	NULL
secretion	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1034	NULL
of	NULL
immunoreactive	NULL
TNF	NULL
by	NULL
murine	NULL
macrophages	NULL
stimulated	NULL
with	NULL
LPS	NULL
.	NULL

These	NULL
observations	NULL
concur	NULL
with	NULL
those	NULL
recently	NULL
reported	NULL
by	NULL
Schmalbach	NULL
et	NULL
al	NULL
``	NULL
``	NULL
showing	NULL
the	NULL
ability	NULL
of	NULL
diethy	NULL
}	NULL
-dithiocarbamate	NULL
to	NULL
augment	NULL
levels	NULL
of	NULL
TNF	NULL
mRNA	NULL
in	NULL
HL-60	NULL
cells	NULL
and	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

The	NULL
mechanism	NULL
underlying	NULL
this	NULL
effect	NULL
remains	NULL
undefined	NULL
,	NULL
although	NULL
antioxidant-induced	NULL
AP-1	NULL
binding	NULL
may	NULL
be	NULL
contributory	NULL
,	NULL
``	NULL
given	NULL
that	NULL
TNF	NULL
gene	NULL
transcription	NULL
is	NULL
at	NULL
least	NULL
partly	NULL
dependent	NULL
on	NULL
an	NULL
AP-1	NULL
site	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
The	NULL
results	NULL
in	NULL
murine	NULL
cells	NULL
differ	NULL
from	NULL
those	NULL
recently	NULL
reported	NULL
by	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
``	NULL
and	NULL
confirmed	NULL
in	NULL
the	NULL
present	NULL
studies	NULL
,	NULL
showing	NULL
the	NULL
ability	NULL
of	NULL
PDTC	NULL
to	NULL
inhibit	NULL
TNF	NULL
gene	NULL
expression	NULL
in	NULL
LPS-stimulated	NULL
human	NULL
monocytes	NULL
.	NULL

Species	NULL
differences	NULL
as	NULL
well	NULL
as	NULL
differences	NULL
in	NULL
the	NULL
level	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
cell	NULL
(	NULL
thioglyco-late-elicited	NULL
macrophages	NULL
versus	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
or	NULL
monocytic	NULL
cell	NULL
line	NULL
)	NULL
may	NULL
account	NULL
for	NULL
these	NULL
disparate	NULL
find-ings	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
antioxidants	NULL
to	NULL
modulate	NULL
macrophage	NULL
TF	NULL
expression	NULL
at	NULL
a	NULL
posttranscriptional	NULL
level	NULL
represents	NULL
a	NULL
novel	NULL
mechanism	NULL
whereby	NULL
these	NULL
agents	NULL
might	NULL
exert	NULL
their	NULL
effects	NULL
on	NULL
cell	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
microbial	NULL
products	NULL
.	NULL

The	NULL
studies	NULL
also	NULL
suggest	NULL
alternative	NULL
clinical	NULL
uses	NULL
for	NULL
antioxidant	NULL
therapy	NULL
.	NULL

Cell-mediated	NULL
initiation	NULL
of	NULL
the	NULL
coagulation	NULL
cascade	NULL
is	NULL
an	NULL
important	NULL
mechanism	NULL
underlying	NULL
the	NULL
fibrin	NULL
deposition	NULL
associated	NULL
with	NULL
multiple	NULL
pathologic	NULL
processes	NULL
,	NULL
including	NULL
intraabdominal	NULL
abscess	NULL
formation	NULL
,	NULL
lung	NULL
injury	NULL
during	NULL
sepsis	NULL
,	NULL
autoimmune	NULL
renal	NULL
disease	NULL
,	NULL
and	NULL
various	NULL
forms	NULL
of	NULL
arthritis	NULL
.	NULL

Furthermore	NULL
,	NULL
because	NULL
TF	NULL
may	NULL
also	NULL
be	NULL
expressed	NULL
by	NULL
macrophages	NULL
in	NULL
atherosclerotic	NULL
plaques	NULL
,	NULL
``	NULL
the	NULL
data	NULL
also	NULL
point	NULL
to	NULL
a	NULL
mechanism	NULL
whereby	NULL
antioxidants	NULL
might	NULL
abrogate	NULL
acute	NULL
thrombosis	NULL
caused	NULL
by	NULL
ulceration	NULL
of	NULL
a	NULL
plaque	NULL
.	NULL

Studies	NULL
using	NULL
in	NULL
vivo	NULL
models	NULL
of	NULL
these	NULL
disease	NULL
processes	NULL
are	NULL
required	NULL
to	NULL
explore	NULL
these	NULL
possibilities	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Grisham	NULL
MB	NULL
:	NULL
Cytotoxic	NULL
activities	NULL
of	NULL
reactive	NULL
oxygen	NULL
metabo-lites	NULL
,	NULL
in	NULL
Grisham	NULL
MB	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Reactive	NULL
Metabolites	NULL
of	NULL
Oxygen	NULL
and	NULL
Nitrogen	NULL
in	NULL
Biology	NULL
and	NULL
Medicine	NULL
.	NULL

Austin	NULL
,	NULL
TX	NULL
,	NULL
R.G	NULL
.	NULL

Landes	NULL
,	NULL
1992	NULL
,	NULL
p	NULL
29	NULL
2	NULL
.	NULL

Granger	NULL
DN	NULL
,	NULL
Hollworth	NULL
ME	NULL
,	NULL
Parks	NULL
DA	NULL
:	NULL
Ischemia-reperfusion	NULL
injury	NULL
:	NULL
role	NULL
of	NULL
oxygen-derived	NULL
free	NULL
radicals	NULL
.	NULL

Acta	NULL
Physiol	NULL
Scand	NULL
548:47	NULL
,	NULL
1986	NULL
(	NULL
suppl	NULL
)	NULL
3	NULL
.	NULL

Deitch	NULL
EA	NULL
,	NULL
Ma	NULL
L	NULL
,	NULL
Ma	NULL
WJ	NULL
:	NULL
Inhibition	NULL
of	NULL
endotoxin-induced	NULL
bacterial	NULL
translocation	NULL
in	NULL
mice	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
84:36	NULL
,	NULL
1989	NULL
4	NULL
.	NULL

Powis	NULL
G	NULL
:	NULL
Free	NULL
radical	NULL
formation	NULL
by	NULL
antitumor	NULL
quinones	NULL
.	NULL

Free	NULL
Radic	NULL
Biol	NULL
Med	NULL
6:63	NULL
,	NULL
1989	NULL
5	NULL
.	NULL

Harman	NULL
D	NULL
:	NULL
;	NULL
Aging	NULL
:	NULL
A	NULL
theory	NULL
based	NULL
on	NULL
free	NULL
radical	NULL
and	NULL
radiation	NULL
chemistry	NULL
.	NULL

J	NULL
Gerontol	NULL
11:298	NULL
,	NULL
1956	NULL
6	NULL
.	NULL

Crawford	NULL
D	NULL
,	NULL
Zbinden	NULL
I	NULL
,	NULL
Amstad	NULL
P	NULL
,	NULL
Cerutti	NULL
P	NULL
:	NULL
Oxidant	NULL
stress	NULL
induces	NULL
the	NULL
protooncogenes	NULL
c-fos	NULL
and	NULL
c-myc	NULL
in	NULL
mouse	NULL
epidermal	NULL
cells	NULL
.	NULL

Oncogene	NULL
3:27	NULL
,	NULL
1988	NULL
7	NULL
.	NULL

Shibanuma	NULL
M	NULL
,	NULL
Kuroki	NULL
T	NULL
,	NULL
Nose	NULL
K	NULL
:	NULL
Induction	NULL
of	NULL
DNA	NULL
replication	NULL
and	NULL
expression	NULL
of	NULL
protooncogenes	NULL
c-myc	NULL
and	NULL
c-fos	NULL
in	NULL
quiescent	NULL
Balb/3T3	NULL
cells	NULL
by	NULL
xanthine/xanthine	NULL
oxidase	NULL
.	NULL

Oncogene	NULL
3:17	NULL
,	NULL
1988	NULL
8	NULL
.	NULL

Devary	NULL
Y	NULL
,	NULL
Gottlieb	NULL
RA	NULL
,	NULL
Lau	NULL
LF	NULL
,	NULL
Karin	NULL
M	NULL
:	NULL
Rapid	NULL
and	NULL
preferential	NULL
activation	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
during	NULL
the	NULL
mammalian	NULL
UV	NULL
response	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:2804	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Nose	NULL
K	NULL
,	NULL
Shibanuma	NULL
M	NULL
,	NULL
Kikuchi	NULL
K	NULL
,	NULL
Kageyama	NULL
H	NULL
,	NULL
Sakiyama	NULL
S	NULL
,	NULL
Kuroki	NULL
T	NULL
:	NULL
Transcriptional	NULL
activation	NULL
of	NULL
early-response	NULL
genes	NULL
by	NULL
hydrogen	NULL
peroxide	NULL
in	NULL
a	NULL
mouse	NULL
osteoblastic	NULL
cell	NULL
line	NULL
.	NULL

Eur	NULL
J	NULL
Biochem	NULL
201:99	NULL
,	NULL
1991	NULL
BRISSEAU	NULL
ET	NULL
AL	NULL
10	NULL
.	NULL

Schreck	NULL
R	NULL
,	NULL
Rieber	NULL
P	NULL
,	NULL
Baeuerle	NULL
PA	NULL
:	NULL
Reactive	NULL
oxygen	NULL
intermediates	NULL
as	NULL
apparently	NULL
widely	NULL
used	NULL
messengers	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-kappa	NULL
B	NULL
transcription	NULL
factor	NULL
and	NULL
HIV-1	NULL
.	NULL

EMBO	NULL
J	NULL
10:2247	NULL
,	NULL
1991	NULL
11	NULL
.	NULL

Schreck	NULL
R	NULL
,	NULL
Meier	NULL
B	NULL
,	NULL
Manel	NULL
DN	NULL
,	NULL
Droge	NULL
W	NULL
,	NULL
Bacuerle	NULL
PA	NULL
:	NULL
Dithiocarbamates	NULL
as	NULL
potent	NULL
inhibitors	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
activation	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
175:1181	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

Abecassis	NULL
M	NULL
,	NULL
Falk	NULL
JA	NULL
,	NULL
Makowka	NULL
L	NULL
,	NULL
Dindzans	NULL
VJ	NULL
,	NULL
Falk	NULL
RE	NULL
,	NULL
Levy	NULL
GA	NULL
:	NULL
16	NULL
,	NULL
16	NULL
Dimethyl	NULL
prostaglandin	NULL
E	NULL
;	NULL
,	NULL
prevents	NULL
the	NULL
development	NULL
of	NULL
fulminant	NULL
hepatitis	NULL
and	NULL
blocks	NULL
the	NULL
induction	NULL
of	NULL
monocyte/	NULL
macrophage	NULL
procoagulant	NULL
activity	NULL
after	NULL
murine	NULL
hepatitis	NULL
virus	NULL
strain	NULL
3	NULL
infection	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
80:881	NULL
,	NULL
1987	NULL
13	NULL
.	NULL

Li	NULL
C	NULL
,	NULL
Fung	NULL
LS	NULL
,	NULL
Chung	NULL
S	NULL
,	NULL
Crow	NULL
A	NULL
,	NULL
Myers-Mason	NULL
N	NULL
,	NULL
Cole	NULL
EH	NULL
,	NULL
Levy	NULL
GA	NULL
:	NULL
Monoclonal	NULL
anti-prothrombinase	NULL
(	NULL
3D4.3	NULL
)	NULL
prevents	NULL
mortality	NULL
from	NULL
murine	NULL
hepatitis	NULL
virus	NULL
infection	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:689	NULL
,	NULL
1992	NULL
14	NULL
.	NULL

Cole	NULL
EH	NULL
,	NULL
Glynn	NULL
MF	NULL
,	NULL
Laskin	NULL
CA	NULL
,	NULL
Sweet	NULL
J	NULL
,	NULL
Mason	NULL
N	NULL
,	NULL
Levy	NULL
GA	NULL
:	NULL
Ancrod	NULL
improves	NULL
survival	NULL
in	NULL
murine	NULL
systemic	NULL
lupus	NULL
erythemato-sus	NULL
.	NULL

Kidney	NULL
Int	NULL
37:29	NULL
,	NULL
1990	NULL
15	NULL
.	NULL

Holdsworth	NULL
SR	NULL
,	NULL
Tipping	NULL
PG	NULL
:	NULL
Macrophage-induced	NULL
glomeru-lar	NULL
fibrin	NULL
deposition	NULL
in	NULL
experimental	NULL
glomerulonephritis	NULL
in	NULL
the	NULL
rabbit	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
76:1367	NULL
,	NULL
1985	NULL
16	NULL
.	NULL

Ferro	NULL
TJ	NULL
,	NULL
Lynch	NULL
JJ	NULL
,	NULL
Malik	NULL
AB	NULL
:	NULL
Macrophages	NULL
activated	NULL
by	NULL
fibrin	NULL
increase	NULL
albumin	NULL
permeability	NULL
across	NULL
pulmonary	NULL
artery	NULL
endothelial	NULL
monolayers	NULL
.	NULL

Am	NULL
Rev	NULL
Respir	NULL
Dis	NULL
139:940	NULL
,	NULL
1989	NULL
17	NULL
.	NULL

Chapman	NULL
HA	NULL
Jr	NULL
,	NULL
Vavrin	NULL
Z	NULL
,	NULL
Hibbs	NULL
JB	NULL
Jr	NULL
:	NULL
Coordinate	NULL
expression	NULL
of	NULL
macrophage	NULL
procoagulant	NULL
and	NULL
fibrinolytic	NULL
activity	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J	NULL
Immunol	NULL
130:261	NULL
,	NULL
1983	NULL
18	NULL
.	NULL

Almdahl	NULL
SM	NULL
,	NULL
Osterud	NULL
B	NULL
,	NULL
Melby	NULL
K	NULL
,	NULL
Giercksky	NULL
K-E	NULL
:	NULL
Mononuclear	NULL
phagocyte	NULL
thromboplastin	NULL
,	NULL
bacterial	NULL
counts	NULL
and	NULL
endotoxin	NULL
levels	NULL
in	NULL
experimental	NULL
endogenous	NULL
gram-negative	NULL
sepsis	NULL
.	NULL

Acta	NULL
Chir	NULL
Scand	NULL
152:351	NULL
,	NULL
1986	NULL
19	NULL
.	NULL

McRitchie	NULL
DI	NULL
,	NULL
Girotti	NULL
MJ	NULL
,	NULL
Glynn	NULL
MF	NULL
,	NULL
Goldberg	NULL
JM	NULL
,	NULL
Rotstein	NULL
OD	NULL
:	NULL
Effect	NULL
of	NULL
systemic	NULL
fibrinogen	NULL
depletion	NULL
on	NULL
intraabdominal	NULL
abscess	NULL
formation	NULL
.	NULL

J	NULL
Lab	NULL
Clin	NULL
Med	NULL
118:48	NULL
,	NULL
1991	NULL
20	NULL
.	NULL

Bach	NULL
RR	NULL
:	NULL
Initiation	NULL
of	NULL
coagulation	NULL
by	NULL
tissue	NULL
factor	NULL
.	NULL

Crit	NULL
Rev	NULL
Biochem	NULL
23:339	NULL
,	NULL
1988	NULL
21	NULL
.	NULL

Mackman	NULL
N	NULL
,	NULL
Imes	NULL
S	NULL
,	NULL
Maske	NULL
WH	NULL
,	NULL
Taylor	NULL
B	NULL
,	NULL
Lusis	NULL
AJ	NULL
,	NULL
Drake	NULL
TA	NULL
:	NULL
Structure	NULL
of	NULL
the	NULL
murine	NULL
tissue	NULL
factor	NULL
gene	NULL
.	NULL

Chromosome	NULL
location	NULL
and	NULL
conservation	NULL
of	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

Arterioscler	NULL
Thromb	NULL
12:474	NULL
,	NULL
1992	NULL
22	NULL
.	NULL

Mackman	NULL
N	NULL
,	NULL
Morrissey	NULL
JH	NULL
,	NULL
Fowler	NULL
B	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Complete	NULL
sequence	NULL
of	NULL
the	NULL
human	NULL
tissue	NULL
factor	NULL
gene	NULL
,	NULL
a	NULL
highly	NULL
regulated	NULL
cellular	NULL
receptor	NULL
that	NULL
initiates	NULL
the	NULL
coagulation	NULL
protease	NULL
cascade	NULL
.	NULL

Biochemistry	NULL
28:1755	NULL
,	NULL
1989	NULL
23	NULL
.	NULL

Mackman	NULL
N	NULL
,	NULL
Brand	NULL
K	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Lipopolysaccharide-mediated	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
tissue	NULL
factor	NULL
gene	NULL
in	NULL
THP-1	NULL
monocytic	NULL
cells	NULL
requires	NULL
both	NULL
activator	NULL
protein	NULL
1	NULL
and	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B	NULL
binding	NULL
sites	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
174	NULL
;	NULL
1517	NULL
,	NULL
1991	NULL
24	NULL
.	NULL

Moldow	NULL
CF	NULL
,	NULL
Bach	NULL
RR	NULL
,	NULL
Staskus	NULL
K	NULL
,	NULL
Rick	NULL
PD	NULL
:	NULL
Induction	NULL
of	NULL
endothelial	NULL
tissue	NULL
factor	NULL
by	NULL
endotoxin	NULL
and	NULL
its	NULL
precursors	NULL
.	NULL

Thromb	NULL
Haemost	NULL
70:702	NULL
,	NULL
1993	NULL
25	NULL
.	NULL

Levy	NULL
GA	NULL
,	NULL
Schwartz	NULL
BS	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
The	NULL
kinetics	NULL
and	NULL
metabolic	NULL
requirements	NULL
for	NULL
direct	NULL
lymphocyte	NULL
induction	NULL
of	NULL
human	NULL
procoagulant	NULL
monokines	NULL
by	NULL
bacterial	NULL
lipopolysaccharide	NULL
.	NULL

J	NULL
Immuno	NULL
!	NULL

127:357	NULL
,	NULL
1981	NULL
26	NULL
.	NULL

Lando	NULL
PA	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Lymphoid	NULL
procoagulant	NULL
response	NULL
to	NULL
bacterial	NULL
endotoxin	NULL
in	NULL
the	NULL
rat	NULL
.	NULL

Infect	NULL
Immun	NULL
50:660	NULL
,	NULL
1985	NULL
27	NULL
.	NULL

Rosenthal	NULL
GA	NULL
,	NULL
Levy	NULL
G	NULL
,	NULL
Rotstein	NULL
OD	NULL
:	NULL
Induction	NULL
of	NULL
macrophage	NULL
procoagulant	NULL
activity	NULL
by	NULL
Bacteroides	NULL
fragilis	NULL
.	NULL

Infect	NULL
Immun	NULL
57:338	NULL
,	NULL
1989	NULL
28	NULL
.	NULL

Whitehead	NULL
TP	NULL
,	NULL
Kricka	NULL
LJ	NULL
,	NULL
Carter	NULL
TJ	NULL
,	NULL
Thorpe	NULL
GH	NULL
:	NULL
Analytical	NULL
luminescence	NULL
:	NULL
Its	NULL
potential	NULL
in	NULL
the	NULL
clinical	NULL
laboratory	NULL
.	NULL

Clin	NULL
Chem	NULL
25:1531	NULL
,	NULL
1979	NULL
29	NULL
.	NULL

Diamondi	NULL
AP	NULL
,	NULL
Christopoulos	NULL
TK	NULL
,	NULL
Diamandis	NULL
EP	NULL
:	NULL
Ultrasensi-tive	NULL
thyrotropin	NULL
immunoassay	NULL
based	NULL
on	NULL
enzymatically	NULL
amplified	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ANTIOXIDANTS	NULL
AND	NULL
MACROPHAGE	NULL
TISSUE	NULL
FACTOR	NULL
time-resolved	NULL
fluorescence	NULL
with	NULL
a	NULL
Terbium	NULL
chelate	NULL
.	NULL

Clin	NULL
Chem	NULL
38:545	NULL
,	NULL
1992	NULL
30	NULL
.	NULL

Allen	NULL
RC	NULL
:	NULL
Phagocytic	NULL
leukocyte	NULL
oxygenation	NULL
activities	NULL
and	NULL
chemiluminescence	NULL
:	NULL
A	NULL
kinetic	NULL
approach	NULL
to	NULL
analysis	NULL
.	NULL

Methods	NULL
Enzy-mol	NULL
133:449	NULL
,	NULL
1986	NULL
31	NULL
.	NULL

Ranganathan	NULL
G	NULL
,	NULL
Blatti	NULL
SP	NULL
,	NULL
Subramaniam	NULL
M	NULL
,	NULL
Fass	NULL
DN	NULL
,	NULL
Maihle	NULL
NJ	NULL
,	NULL
Getz	NULL
MJ	NULL
:	NULL
Cloning	NULL
of	NULL
murine	NULL
tissue	NULL
factor	NULL
and	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
transforming	NULL
growth	NULL
factor	NULL
type	NULL
beta	NULL
1	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:496	NULL
,	NULL
1991	NULL
32	NULL
.	NULL

Pennica	NULL
D	NULL
,	NULL
Hayflick	NULL
JS	NULL
,	NULL
Bringman	NULL
TS	NULL
,	NULL
Palladino	NULL
MA	NULL
,	NULL
Goed-del	NULL
DV	NULL
:	NULL
Cloning	NULL
and	NULL
expression	NULL
in	NULL
Escherichia	NULL
coli	NULL
of	NULL
the	NULL
cDNA	NULL
for	NULL
murine	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
82:6060	NULL
,	NULL
1985	NULL
33	NULL
.	NULL

Chomczynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
34	NULL
.	NULL

Lemischka	NULL
I	NULL
,	NULL
Sharp	NULL
PA	NULL
:	NULL
The	NULL
sequences	NULL
of	NULL
an	NULL
expressed	NULL
rat	NULL
alpha-tubulin	NULL
gene	NULL
and	NULL
a	NULL
pseudogene	NULL
with	NULL
an	NULL
inserted	NULL
repetitive	NULL
element	NULL
.	NULL

Nature	NULL
300:330	NULL
,	NULL
1982	NULL
35	NULL
.	NULL

Zanocco	NULL
AL	NULL
,	NULL
Pavez	NULL
R	NULL
,	NULL
Videla	NULL
LA	NULL
,	NULL
Lissi	NULL
EA	NULL
:	NULL
Antioxidant	NULL
capacity	NULL
of	NULL
diethyldithiocarbamate	NULL
in	NULL
a	NULL
metal	NULL
independent	NULL
lipid	NULL
per-oxidative	NULL
process	NULL
.	NULL

Free	NULL
Radic	NULL
Biol	NULL
Med	NULL
7:151	NULL
,	NULL
1989	NULL
36	NULL
.	NULL

Moldeus	NULL
P	NULL
,	NULL
Berggren	NULL
M	NULL
,	NULL
Grafstrom	NULL
R	NULL
:	NULL
N-acetyl-cysteine	NULL
protection	NULL
against	NULL
the	NULL
toxicity	NULL
of	NULL
cigarette	NULL
smoke	NULL
and	NULL
cigarette	NULL
smoke	NULL
condensates	NULL
in	NULL
various	NULL
tissues	NULL
and	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

Eur	NULL
J	NULL
Respir	NULL
Dis	NULL
66:123	NULL
,	NULL
1985	NULL
(	NULL
suppl	NULL
139	NULL
)	NULL
37	NULL
.	NULL

Thor	NULL
H	NULL
,	NULL
Moldeus	NULL
P	NULL
,	NULL
Orrenius	NULL
S	NULL
:	NULL
Metabolic	NULL
activation	NULL
and	NULL
hepatotoxicity	NULL
.	NULL

Effect	NULL
of	NULL
cysteine	NULL
,	NULL
N-acetyl-cysteine	NULL
and	NULL
methionine	NULL
on	NULL
glutathione	NULL
biosynthesis	NULL
and	NULL
bromobenzene	NULL
toxicity	NULL
in	NULL
isolated	NULL
rat	NULL
hepatocytes	NULL
.	NULL

Arch	NULL
Biochem	NULL
Biophys	NULL
192:405	NULL
,	NULL
1979	NULL
38	NULL
.	NULL

Drake	NULL
TA	NULL
,	NULL
Ruf	NULL
W	NULL
,	NULL
Morrissey	NULL
JH	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Functional	NULL
tissue	NULL
factor	NULL
is	NULL
entirely	NULL
cell	NULL
surface	NULL
expressed	NULL
on	NULL
lipopolysaccharide-stimulated	NULL
human	NULL
blood	NULL
monocytes	NULL
and	NULL
a	NULL
constitutively	NULL
tissue	NULL
factor-producing	NULL
neoplastic	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
109:389	NULL
,	NULL
1989	NULL
39	NULL
.	NULL

Prydz	NULL
H	NULL
,	NULL
Allison	NULL
AC	NULL
:	NULL
Tissue	NULL
thromboplastin	NULL
activity	NULL
of	NULL
isolated	NULL
human	NULL
monocytes	NULL
.	NULL

Thromb	NULL
Haemost	NULL
39:582	NULL
,	NULL
1978	NULL
40	NULL
.	NULL

Gregory	NULL
SA	NULL
,	NULL
Morrissey	NULL
JH	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Regulation	NULL
of	NULL
tissue	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
the	NULL
monocyte	NULL
procoagulant	NULL
response	NULL
to	NULL
endotoxin	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
9:2752	NULL
,	NULL
1989	NULL
41	NULL
.	NULL

Morrissey	NULL
JH	NULL
,	NULL
Fair	NULL
DS	NULL
,	NULL
Edgington	NULL
TS	NULL
:	NULL
Monoclonal	NULL
antibody	NULL
analysis	NULL
of	NULL
purified	NULL
and	NULL
cell-associated	NULL
tissue	NULL
factor	NULL
.	NULL

Thromb	NULL
Res	NULL
52:247	NULL
,	NULL
1988	NULL
42	NULL
.	NULL

Paborsky	NULL
LR	NULL
,	NULL
Harris	NULL
RJ	NULL
:	NULL
;	NULL
Post-translational	NULL
modifications	NULL
of	NULL
recombinant	NULL
human	NULL
tissue	NULL
factor	NULL
.	NULL

Thromb	NULL
Res	NULL
60:367	NULL
,	NULL
1990	NULL
43	NULL
.	NULL

Malter	NULL
JS	NULL
,	NULL
Hong	NULL
Y	NULL
:	NULL
A	NULL
redox	NULL
switch	NULL
and	NULL
phosphorylation	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
post-translational	NULL
up-regulation	NULL
of	NULL
the	NULL
adenosine-uridine	NULL
binding	NULL
factor	NULL
by	NULL
phorbol	NULL
ester	NULL
and	NULL
ionophore	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:3167	NULL
,	NULL
1991	NULL
44	NULL
,	NULL
Hentze	NULL
MW	NULL
,	NULL
Rouault	NULL
TA	NULL
,	NULL
Harford	NULL
JB	NULL
,	NULL
Klausner	NULL
RD	NULL
:	NULL
Oxida-tion-reduction	NULL
and	NULL
the	NULL
molecular	NULL
mechanism	NULL
of	NULL
a	NULL
regulatory	NULL
RNA-protein	NULL
interaction	NULL
.	NULL

Science	NULL
244:357	NULL
,	NULL
1989	NULL
45	NULL
.	NULL

Young	NULL
J	NULL
,	NULL
Kane	NULL
LP	NULL
,	NULL
Exley	NULL
M	NULL
,	NULL
Wileman	NULL
T	NULL
:	NULL
Regulation	NULL
of	NULL
selective	NULL
protein	NULL
degradation	NULL
in	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
by	NULL
redox	NULL
po-tential	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:19810	NULL
,	NULL
1993	NULL
1035	NULL
46	NULL
.	NULL

Braakman	NULL
I	NULL
,	NULL
Helenius	NULL
J	NULL
,	NULL
Helenius	NULL
A	NULL
:	NULL
Manipulating	NULL
disulfide	NULL
bond	NULL
formation	NULL
and	NULL
protein	NULL
folding	NULL
in	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
.	NULL

EMBO	NULL
J	NULL
11:1717	NULL
,	NULL
1992	NULL
47	NULL
.	NULL

Hwang	NULL
C	NULL
,	NULL
Sinskey	NULL
AJ	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Oxidized	NULL
redox	NULL
state	NULL
of	NULL
glutathione	NULL
in	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
.	NULL

Science	NULL
257:1496	NULL
,	NULL
1992	NULL
48	NULL
.	NULL

Jaattela	NULL
M	NULL
:	NULL
Biologic	NULL
activities	NULL
and	NULL
mechanisms	NULL
of	NULL
action	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-alpha/cachectin	NULL
.	NULL

Lab	NULL
Invest	NULL
64:724	NULL
,	NULL
1991	NULL
49	NULL
.	NULL

Lentz	NULL
SR	NULL
,	NULL
Sadler	NULL
JE	NULL
:	NULL
Homocysteine	NULL
inhibits	NULL
von	NULL
Willebrand	NULL
factor	NULL
processing	NULL
and	NULL
secretion	NULL
by	NULL
preventing	NULL
transport	NULL
from	NULL
the	NULL
endoplasmic	NULL
reticulum	NULL
.	NULL

Blood	NULL
81:683	NULL
,	NULL
1993	NULL
50	NULL
.	NULL

Satriano	NULL
JA	NULL
,	NULL
Shuldiner	NULL
M	NULL
,	NULL
Hora	NULL
K	NULL
,	NULL
Xing	NULL
Y	NULL
,	NULL
Shan	NULL
Z	NULL
,	NULL
Schlon-dorff	NULL
D	NULL
:	NULL
Oxygen	NULL
radicals	NULL
as	NULL
second	NULL
messengers	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
monocyte	NULL
chemoattractant	NULL
protein	NULL
,	NULL
JE/MCP-1	NULL
,	NULL
and	NULL
the	NULL
monocyte	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
CSF-1	NULL
,	NULL
in	NULL
response	NULL
to	NULL
tumor	NULL
necrosis	NULL
fac-tor-a	NULL
and	NULL
immunoglobulin	NULL
G.	NULL
Evidence	NULL
for	NULL
involvement	NULL
of	NULL
reduced	NULL
nicotinamide	NULL
adenine	NULL
dinucleotide	NULL
phosphate	NULL
(	NULL
NADPH	NULL
)	NULL
-dependent	NULL
oxidase	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
92:1564	NULL
,	NULL
1993	NULL
51	NULL
.	NULL

Marui	NULL
N	NULL
,	NULL
Offermann	NULL
MK	NULL
,	NULL
Swerlick	NULL
R	NULL
,	NULL
Kunsch	NULL
C	NULL
,	NULL
Rosen	NULL
CA	NULL
,	NULL
Ahmad	NULL
M	NULL
,	NULL
Alexander	NULL
RW	NULL
,	NULL
Medford	NULL
RM	NULL
:	NULL
Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
gene	NULL
transcription	NULL
and	NULL
expression	NULL
are	NULL
regulated	NULL
through	NULL
an	NULL
antioxidant-sensitive	NULL
mechanism	NULL
in	NULL
human	NULL
vascular	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
92:1866	NULL
,	NULL
1993	NULL
52	NULL
.	NULL

Israel	NULL
N	NULL
,	NULL
Gougerot-Pocidalo	NULL
M-A	NULL
,	NULL
Aillet	NULL
F	NULL
,	NULL
Virelizier	NULL
J-L	NULL
:	NULL
Redox	NULL
status	NULL
of	NULL
cells	NULL
influences	NULL
constitutive	NULL
or	NULL
induced	NULL
NF-kB	NULL
translocation	NULL
and	NULL
HIV	NULL
long	NULL
terminal	NULL
repeat	NULL
activity	NULL
in	NULL
human	NULL
T	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
Immunol	NULL
149	NULL
;	NULL
3386	NULL
,	NULL
1992	NULL
53	NULL
.	NULL

Ziegler-Heitbrock	NULL
HWL	NULL
,	NULL
Sternsdorf	NULL
T	NULL
,	NULL
Liese	NULL
J	NULL
,	NULL
Belohradsky	NULL
B	NULL
,	NULL
Weber	NULL
C	NULL
,	NULL
Wedel	NULL
A	NULL
,	NULL
Schreck	NULL
R	NULL
,	NULL
Baeuerle	NULL
P	NULL
,	NULL
Strobel	NULL
M	NULL
:	NULL
Pyrrolidine	NULL
dithiocarbamate	NULL
inhibits	NULL
NF-kappaB	NULL
mobilization	NULL
and	NULL
TNF	NULL
production	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
151:6986	NULL
,	NULL
1993	NULL
54	NULL
.	NULL

Meyer	NULL
M	NULL
,	NULL
Schreck	NULL
R	NULL
,	NULL
Baeuerle	NULL
PA	NULL
:	NULL
H	NULL
,	NULL
O	NULL
;	NULL
and	NULL
antioxidants	NULL
have	NULL
opposite	NULL
effects	NULL
on	NULL
activation	NULL
of	NULL
NF-kappaB	NULL
and	NULL
AP-1	NULL
in	NULL
intact	NULL
cells	NULL
:	NULL
AP-1	NULL
as	NULL
secondary	NULL
antioxidant-responsive	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
12:2005	NULL
,	NULL
1993	NULL
55	NULL
.	NULL

Schmalbach	NULL
TK	NULL
,	NULL
Datta	NULL
R	NULL
,	NULL
Kufe	NULL
DW	NULL
,	NULL
Sherman	NULL
ML	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
cytokine	NULL
expression	NULL
by	NULL
diethyldithiocarbamate	NULL
in	NULL
human	NULL
HL-60	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Biochem	NULL
Pharmacol	NULL
44:365	NULL
,	NULL
1992	NULL
56	NULL
.	NULL

Rhoades	NULL
KL	NULL
,	NULL
Golub	NULL
SH	NULL
,	NULL
Economou	NULL
JS	NULL
:	NULL
The	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
promoter	NULL
region	NULL
in	NULL
macrophage	NULL
,	NULL
T	NULL
cell	NULL
,	NULL
and	NULL
B	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:22102	NULL
,	NULL
1992	NULL
57	NULL
.	NULL

Economou	NULL
JS	NULL
,	NULL
Rhoades	NULL
K	NULL
,	NULL
Essner	NULL
R	NULL
,	NULL
McBride	NULL
WH	NULL
,	NULL
Gasson	NULL
JC	NULL
,	NULL
Morton	NULL
DL	NULL
:	NULL
Genetic	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a/cachectin	NULL
promoter	NULL
region	NULL
in	NULL
a	NULL
macrophage	NULL
cell	NULL
line	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
170:321	NULL
,	NULL
1989	NULL
58	NULL
.	NULL

Takashiba	NULL
S	NULL
,	NULL
Shapira	NULL
L	NULL
,	NULL
Amar	NULL
S	NULL
,	NULL
Van	NULL
Dyke	NULL
TE	NULL
:	NULL
Cloning	NULL
and	NULL
characterization	NULL
of	NULL
human	NULL
TNF	NULL
a	NULL
promoter	NULL
region	NULL
.	NULL

Gene	NULL
131:307	NULL
,	NULL
1993	NULL
59	NULL
.	NULL

Tipping	NULL
PG	NULL
,	NULL
Malliaros	NULL
J	NULL
,	NULL
Holdsworth	NULL
SR	NULL
:	NULL
Procoagulant	NULL
activity	NULL
expression	NULL
by	NULL
macrophages	NULL
from	NULL
atheromatous	NULL
vascular	NULL
plaques	NULL
.	NULL

Atherosclerosis	NULL
79:237	NULL
,	NULL
1989	NULL
60	NULL
.	NULL

Wilcox	NULL
JS	NULL
,	NULL
Smith	NULL
KM	NULL
,	NULL
Schwartz	NULL
SM	NULL
,	NULL
Gordon	NULL
D	NULL
:	NULL
Localization	NULL
of	NULL
tissue	NULL
factor	NULL
in	NULL
the	NULL
normal	NULL
vessel	NULL
and	NULL
in	NULL
the	NULL
atherosclerotic	NULL
plaque	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:2839	NULL
,	NULL
1989	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1995	NULL
85	NULL
:	NULL
1025-1035	NULL
Posttranscriptional	NULL
regulation	NULL
of	NULL
macrophage	NULL
tissue	NULL
factor	NULL
expression	NULL
by	NULL
antioxidants	NULL
4	NULL
_	NULL
5	NULL
,	NULL
'	NULL
_	NULL
>	NULL
,	NULL
#	NULL
04	NULL
;	NULL
©1004	NULL
@	NULL
207	NULL
GF	NULL
Brisseau	NULL
,	NULL
AP	NULL
Dackiw	NULL
,	NULL
PY	NULL
Cheung	NULL
,	NULL
N	NULL
Christie	NULL
and	NULL
OD	NULL
Rotstein	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/85/4/1025.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

